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With the increase in survival for children with cancer, part of the focus of current 
research is aimed towards evaluating how these children are adapting psychosocially. 
Neurocognitive deficits have been well established. However, there are multiple facets 
encompassing quality of life, including general mental health, lifestyles and health 
behaviors, and academic and cognitive functioning. The relationship between 
neurocognitive and psychosocial functioning has yet to be thoroughly evaluated. The 
purpose of this study was to investigate the relationship between neurocognitive and 
psychosocial functioning in survivors of brain tumors and acute lymphoblastic leukemia.  
Data was collected from existing archival database comprised of patients of the 
at Cook Children‘s Medical Center in Texas. The sample consisted of 177 patients 
between the ages of 3 and 12 who were at least two years post-diagnosis. Measures 
used included the NEPSY and the Behavioral Assessment for Children. Statistical 
analyses included a several one-way analysis of variances, an independent samples t-
test, a univariate analysis of variance, a hierarchical multiple regression, and odds ratio 
analyses.   
Results indicated survivors treated with neurosurgery alone appear to be less at 
risk for developing behavior problems than other treatment modalities. Also, brain 
tumor survivors demonstrate more problematic behaviors than survivors of acute 
lymphoblastic leukemia. Visuospatial functioning, diagnosis, and type of treatment were 
found to be predictive variables of behavior problems. Attention, and perhaps language, 
deficits may predispose children to more problems in their behavior.  
It is concluded that there are other factors affecting behavior in this population 
that were not accounted for in this analysis. It is recommended for future studies to 
research the individual clinical scales of the Behavior Assessment System for Children, 
obtain information from multiple informants, study this relationship longitudinally, and 
research additional factors that may be influencing the relationship between 
neurocognitive and psychosocial functioning. This provides evidence of risk factors that 
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Pediatric cancer is the second leading cause of death in children under the age of 
15 in the United States, with 9,100 new cases diagnosed each year. Of these children, 
half are diagnosed with leukemia or some form of malignant brain tumor (Altman & 
Sarg, 2000). With advances in hematological and oncological treatment, the current 
five- year survival rate is 77%, a 45% increase from 1960 (American Cancer Society, 
2003). In 2000, 1 in 900 people in the United States between the ages of 15 and 44 
were survivors of childhood cancer (Bleyer, 1990). Improvements in survival can be 
attributed to the introduction of new and improved therapies, namely chemotherapy, 
bone marrow transplants (BMT) and radiation therapy; centralization of care; and 
improved supportive care, including the introduction of antiemetic drugs and central 
venous catheters (Eiser, 2004). 
Childhood Cancer Diagnoses 
Leukemia 
Leukemia, simply defined, is a class of hematological malignancies in which 
immortal clones of immature blood cells multiply at the expense of normal blood cells 
(Venes, 2001). As a consequence, several side-effects are possible, such as anemia, 
hemorrhage, or eventual death. Most leukemias cause white blood cells to reproduce 
abnormally, possibly infiltrating vital organs and glands, causing them to enlarge and 
malfunction (Altman & Sarg, 2000). Leukemia accounts for one third of all cancer cases 
in children under the age of 15, thus making it the most common type of pediatric 
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cancer (American Cancer Society, 2003).  Despite the 61% decline in mortality rates 
over the past three decades, leukemia is still the leading cause of death in children 
under the age of 15 (American Cancer Society, 2003). However, the long-term survival 
rate for leukemia ranges between 70 to 80%, depending on the type of leukemia 
(Margolin & Poplack, 1997).  
Each year, nearly 3,700 children in the United States are diagnosed with 
leukemia, 2,800 of them diagnosed with acute lymphoblastic leukemia (ALL; American 
Cancer Society, 2003). ALL is the product of the multiplication of mutated B- or T-cell 
lymphoid cells in the blood, bone marrow, and body tissues (Venes, 2001; Margolin, 
Steuber, & Poplack, 2001). It is the most common childhood cancer, accounting for 
almost one-third of all childhood cancers (American Cancer Society, 2002). The average 
age of onset is four years, usually affecting Caucasians and males more often (The 
University of Texas MD Anderson Cancer Center, 2001). Of children with ALL, 
approximately 30% will experience a relapse (American Cancer Society, 1997). 
 Genetic chromosomal abnormalities may contribute to the development of ALL 
(Margolin et al., 2001). Other proposed etiologies, including exposure to radiation and 
toxic chemicals, viral infections, and immunodeficiency have been found to have an 
indirect, if any, contribution to the development of ALL (Margolin et al., 2001). 
The most common symptoms of ALL include: anemia, which is present in 80% of 
patients; fever; bleeding; and bone pain (Margolin et al., 2001). Tools used in 
diagnosing ALL include light microscopy and cytochemical stains, immunophenotyping, 
cytogenetic slides, and molecular analysis. The most significant prognostic indicator of 
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ALL is elevation in leukocyte counts (Margolin et al., 2001). Once diagnosed, children 
are classified as either standard or high risk. If children are between the ages of one 
and nine with a white blood cell (WBC) count less than 50,000/µL, they fall into the 
standard risk range, with a cure rate of over 80% (Gaynon, Angiolilo, Franklin, & 
Reaman, 2003). When the child is older than age ten and has a WBC count over 50,000 
/µL, they are classified as high-risk.  
Treatment of ALL may include chemotherapy, radiation therapy, and in higher 
risk groups or relapse groups, bone marrow transplant (Jabbour, Faderl, & Kantarjian, 
2005). The most common form of treatment is chemotherapy, often followed by 
radiation therapy (Jabbour et al., 2005). Bone marrow relapse occurs in 30% of 
children with ALL, while central nervous system (CNS) relapse occurs in 5-10% of cases 
(American Cancer Society, 1997). 
Brain Tumors 
The American Brain Tumor Association (ABTA) defines brain tumors as 
abnormal growths in the brain resulting from cells reproducing in an uncontrolled 
manner (American Brain Tumor Association, 2005). Brain tumors represent the second 
most common form of pediatric cancer, secondary to leukemia, affecting 3.45 per 
100,000 children in children younger than age 15 (Tomita, 2000). Each year, 2,200 
brain tumors are diagnosed in children and adolescents in the United States (Bleyer, 
1999). The prevalence of brain tumors in children is between 2.2 and 2.5 per 100,000, 
accounting for 17% of pediatric cancer cases (Spreen, Risser, & Edgell, 1995). Brain 
tumors are the leading cause of death from childhood cancer. In1997, brain tumors 
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accounted for 24% of cancer-related deaths in children younger than 19 (Fuemmeler, 
Elkin & Mulhern, 2002; National Institute of Neurological Disorders and Stroke, 2001). 
Presenting Signs   
Although tumors can arise from any brain structure, obstruction of CSF is a 
common presenting sign, which leads to hydrocephalus, leading to increased 
intracranial pressure, which causes headaches, vomiting, visual impairment, and 
lethargy (Ater, Weinberg, Maor, Moore, & Copeland, 2005). Seizures, changes in 
personality and behavior, such as irritability, symptoms of depression, and suicidal 
thoughts), and endocrine changes, may also be presenting signs of brain tumors (van 
Eys, 1991). Furthermore, listlessness, failure to thrive, loss of developmental milestones, 
focal neurologic deficits/hemiparesis, neuro-endocrine dysfunction, changes in appetite, 
cranial neuropathies, ataxia, neck pain, and long tract signs (paraparesis or 
hyperreflexia) are potential presenting symptoms (Ulrich & Pomeroy, 2003).  
Certain presenting symptoms may aid in determining the location of the tumor. 
Localizing symptoms of tumors in the brainstem include diplopia and gaze palsy 
(Strother, Pollack, Fisher, Hunter, Woo, Pomeroy, et al., 2002). Symptoms of 
supratentorial tumors, defined as tumors in the cerebrum, basal ganglia, thalamus, 
hypothalamus, and optic chiasm, may include vision loss (Strother et al., 2002). Signs 
of infratentorial tumors, located in either the cerebellum or brainstem may include 
ataxia, gait disturbances, handwriting changes, and speech difficulties, such as 
dysarthria (Strother et al., 2002). 
Most Prevalent Types of Brain Tumors in Pediatric Population 
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The most common type of brain tumor in children is glial-cell tumors, also known 
as astrocytomas, accounting for 52% of all CNS malignancies in children (Fuemmeler et 
al., 2002). Astrocytomas are star-shaped cells arising from connective tissue, found 
mostly in the cerebrum, and described by their degree of malignancy. Degrees of 
malignancy include low-grade, mid-grade, and high-grade. Low-grade astrocytomas are 
usually benign, such as juvenile benign pilocytic astrocymtoma, found in the parietal 
lobe, and treated typically by surgery alone (Armstrong & Mulhern, 1999). Mid-grade 
astrocytomas include anaplastic astrocytomas. With a five-year survival rate, prognosis 
is between 73 and 95% (Fuemmeler et al., 2002). High grade astrocytomas, such as 
glioblastoma multiforme, are the more likely to spread to neighboring healthy tissue 
and are aggressive (American Brain Tumor Association, 2005). Treatment usually 
involves neurosurgery in combination with radiation therapy. The 5-year survival rate 
ranges between 4 and 37% (Fuemmeler et al., 2002).  
The second most common type of brain tumor found in children is 
medulloblastomas. Medulloblastomas are the most common form of primitive 
neuroepithelial tumors (PNETs) localized in the cerebellum, and may spread to the rest 
of the brain or spinal cord (Altman & Sarg, 2000). They account for 10-20% of all 
childhood brain tumors (Ulrich & Pomeroy, 2003; Fuemmeler et al, 2002). 
Medulloblastomas affect boys four times more frequently than girls and 80% are 
identified in children before the age of 14 (Armstrong & Mulhern, 1999). Treatment 
typically involves surgery, followed by one year of chemotherapy and radiation therapy. 
The five-year survival rate ranges between 40 to 50% (Armstrong & Mulhern, 1999).   
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Brain stem gliomas are the third most common form of brain tumor found in 
children (Fuemmeler et al., 2002). These tumors may grow rapidly or slowly, but rarely 
spread from their original location (Altman & Sarg, 2000). Surgical resection is possible 
for isolated tumors that arise out of the brain stem, in the medulla, and in the upper 
portion of the spinal cord. However, brainstem gliomas are not typically treated by 
surgery because of their remote location and the complex areas they control (Medical 
College of Central Georgia, 2002). Typically, treatment involves whole-brain radiation 
therapy.  In most cases, survival is only one-year post diagnosis (Fuemmeler et al., 
2002). 
Finally, ependymal tumors account for 5-10% of all pediatric brain tumors (Ater 
et al., 2005). These tumors begin in the ependyma, which is a membrane in the brain 
that stores cerebrospinal fluid (Venes, 2001). Approximately 60% of cases are 
diagnosed in children before the age of five (Varni, Blount, & Quiggins, 1998). 
Treatment usually involves surgical resection, followed by radiation therapy. Often, a 
shunt is required to reduce intracranial pressure in the patient (American Brain Tumor 
Association, 2005). In 2002, survival rates ranged between 30 and 67% (Fuemmeler et 
al., 2002). 
Late effects 
Of supratentorial tumors, including low-grade and high-grade astrocytomas, 
associated late effects include poor cognitive function, poor manual dexterity, emotional 
difficulties, seizures, eye-hand coordination problems, hemiplegia, and poorer overall 
quality of life. In infratentorial tumors, including cerebellar astrocytomas and 
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ependymoma, late-effects may include ataxia, primary thyroid dysfunction, or ovarian 
dysfunction (Anderson, Rennie, Ziegler, Neglia, Robinson, & Gurney, 2001). Additional 
late side-effects may include pain, seizures, and sensory loss (Anderson et al., 2001). 
Barr, Simpson, Whitton, Rush, Furlong, and Feeny (1999) found that one-third of 
44 children with brain tumors experienced chronic pain. Pediatric brain tumor survivors 
may also be at risk for visual and hearing impairment. Foreman, Faestel, Pearson, 
Disabato, Poole, Wilkening, et al. (1999) found that 19% of long-term survivors 
experienced frequent pain and 15% were deaf, blind, or mute. 
Treatments Used in Pediatric Cancer Population 
Neurosurgery 
Many brain tumors are treated via neurosurgery, which actually places brain 
structures at further risk for damage (Armstrong, Blumberg, & Toledo, 1999). In truth, 
neurosurgery is often the primary treatment for brain tumors in children (Tomita, 2000). 
The more complete the resection, the better the outcome (Strother et al., 2002). The 
more complete resections improve the efficacy of additional therapies, i.e. 
chemotherapy and radiotherapy (Ater et al., 2005). Other functions of neurosurgery are 
to reduce intracranial pressure and for diagnostic purposes (Ater et al., 2005). Prior to 
surgery, it is safer if increased intracranial pressure can be relieved via external 
ventricular shunts (Ater et al., 2005). Corticosteroids may also be given prior to surgery 




Complications of surgery may result from the necessity of the surgeon to remove 
sections of normal brain tissue to completely remove the tumor (Shenoy, n.d.). Some 
children may become blind, experience severe coordination problems, ataxia, or speech 
and language difficulties (Mulhern, 1994). Early side effects may include cosmetic 
changes, hormone or fluid imbalance, seizures, problems with sight, speech, hearing, 
movement, strength, learning (Shenoy, n.d.). Mortality resulting from neurosurgery is 
around 1% for experienced surgeons (Albright, 1993). 
Chemotherapy 
Chemotherapy drugs are used in the pediatric cancer population for several 
reasons: in multi-drug regimens to overcome drug resistance and increase chances for 
complete cancer remission (combination chemotherapy) and after radiation therapy 
and/or surgery to reduce the risk of metastatic recurrence (adjuvant chemotherapy; 
Adamson, Balis, Berg, & Blaney, 2006).  
Method of Action 
Many forms of anticancer drugs interrupt the formation or function of 
deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) cells. The goal of 
chemotherapeutic agents is to damage the DNA of cancer cells, stop cancer cells from 
replicating by stopping the creation of new DNA strands, or ending cancer cell division 
and cancer progression (Ophardt, 2003). For example, certain chemotherapeutic agents 
may interrupt topisomerases, a stage critical for DNA maintenance, causing strands of 
DNA to tear (Adamson et al., 2006). In response to the effects of most cancers in 
disrupting normal cell functioning (namely the cell cycle and programmed cell death), 
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the mechanism of chemotherapeutic agents is to induce cell death (apoptosis) in cells 
sensitive to them (Adamson et al., 2006). 
Delivery Mechanisms 
Intrathecal chemotherapy (ITC) is a technique used to administer 
chemotherapeutic agents directly into the cerebral spinal fluid (CSF) space, allowing 
tumor cells to be exposed to higher concentrations of the drugs (Tomita, 2000). 
Intrathecal chemotherapy may be administered via frequent spinal taps or via Omaya 
reservoir, which involves implanting a catheter into the lateral ventricle (Tomita, 2000). 
This technique is superior to spinal taps because it is less painful for the child and 
allows for better distribution of the chemotherapeutic agent throughout the CSF 
(Tomita, 2000). Systemic chemotherapy, on the other hand, is administered into a vein, 
muscle, or is swallowed as a pill. This mechanism delivers the chemotherapeutic agent 
throughout the body, making it a useful technique for diseases such as lymphoma 
(American Cancer Society, 2006). 
Types of Chemotherapeutic Drugs 
Antimetabolites. 
Antimetabolities are chemotherapeutic drugs most effective in interfering with 
cells that are synthesizing DNA (Adamson et al., 2006). These agents act to increase 
the amount of the tumor cell population exposed to their drug during DNA replication, 
making defective DNA or RNA products (Adamson et al., 2006).  
Methotrexate, one of the most common antimetobolite agents used in pediatric 
oncology, is a structural analog to folic acid (Adamson et al., 2006). It is often used for 
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treatment of ALL, lymphoma, and osteosarcoma. Since cell enzymes mistake 
methotrexate as folic acid, these cells bind strongly with the drug. This causes the 
conversion of folic acid to tetrahydrofolic acid, necessary for DNA synthesis, to not 
occur. Thus, tumor cell division is halted (Ophardt, 2003). Methotrexate doses typically 
range between 7.7 to 30.0 mg and are administered via oral, muscular, subcutaneous, 
intrathecal, or intravenous (IV) routes (Adamson et al., 2006). Methotrexate may cause 
learning difficulties, precipitate seizures, cause permanent damage to the liver and 
kidneys, and weaken bones (Shenoy, n.d.). Other toxic effects from methotrexate 
exposure may include hepatic toxicity, mucositis, and osteopathy (Adamson et al., 
2006).  
Alkylating Agents. 
Alkylating agents are chemotherapy agents used to treat cancer because of their 
ability to interfere with cell metabolism (Venes, 2001). There are three mechanisms in 
which these agents prevent tumor cells from the miscoding DNA (Ophardt, 2003). One 
mechanism damages DNA templates via the DNA crosslinks, which are bonds between 
atoms in DNA, interrupting synthesis or transcription of DNA (Ophardt, 2003). The 
second mechanism inhibits DNA mutation by causing the mispairing of nucleotides, the 
structural unit of DNA and RNA. Finally, alkylating agents work by attempting to 
fragment DNA by attaching alkyl agents to DNA bases (Ophardt, 2003).  
Higher doses for alkylating agents are used due to the high drug-response 
relationship. Side-effects may include, but are not limited to, inhibition of the function 
of bone marrow (myelosuppression; Venes, 2001), allergic reactions, nausea, and 
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gastrointestinal toxicity (Adamson et al., 2006). More long-term effects can negatively 
influence future reproduction via gonad atrophy, renal effects, scarring of the lungs, 
and kidney damage (Adamson et al., 2006).  
The most commonly used of the alkylating agents are the nitrogen mustards and 
the nitrosoureas. Cyclophosphamide, a type of nitrogen mustard, is one of the most 
used anticancer drugs in the pediatric population. Typical doses range from 250-1800 
mg and are administered via IV. This drug is often used to treat neuroblastomas, 
leukemia, lymphomas, and sacromas (Adamson et al., 2006). Of the nitrosoureas, 2-
chloroethyl derivatives, carmustine, and lomustine are the most commonly used. Less 
commonly used groups include ethylenimes, alkysulfonates, triazenes, and piperazines 
(Ophardt, 2003). 
Antitumor Antibiotics. 
Antitumor antibiotics stop tumor cell reproduction by squeezing between the 
base pairs of the DNA double helix (known as intercalation) and interfering with the 
shape structure of the DNA strands (Adamson et al., 2006). The drugs from this 
category used in the pediatric cancer include anthracyclines, mitroxantrone, 
dactinomycin, and bleomycin.  
The anthracyclines are the most widely used of the antitumor antibiotics 
(Ophardt, 2003). These drugs function by interfering with topiosomerases, preventing 
DNA tangling by severing and reattaching DNA strands during DNA functions (Adamson 
et al., 2006). Examples of anthracyclines include doxorubicin, daunomycin, and 
idarubicin. Doxorubicin is often used to treat solid tumors, while daunomycin and 
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idarubicin are used to treat leukemias and lymphomas (Adamson et al., 2006; Ophardt, 
2003).  
Mitroxantrone is used to treat leukemias and lymphomas (Adamson et al., 2006). 
Functioning similarly to the anthracyclines, mitroxantrone causes breaks in the DNA 
strands. Mitroxantrone is typically administered daily at 8 to 12 mg doses. Side-effects 
may include a bluish tint of the fingernails, sclera, and urine, mild nausea, alopecia, and 
myelosuppression (Adamson et al., 2006).  
Although dactinomycin has been in use for 40 years, it has largely been replaced 
by the anthracyclines for treatment (Adamson et al., 2006). This drug functions as an 
anticancer drug by binding to the DNA and causing breaks in the DNA strands, blocking 
elongation of the DNA chain (Adamson et al., 2006; Ophardt, 2003). Dactinomycin is 
administered via IV at 0.45 mg doses. The bleomycins are used to treat lymphomas and 
testicular cancers. 
Plant products. 
Three different plant derivatives used in treatment of childhood cancer, including 
the vinca alkaloids, derived from the periwinkle plant; the epipodophyllotoxins, derived 
from mandrake roots; and the taxanes, derived from the Camptotheca acuminata tree, 
are still under investigation for their utility in the pediatric oncology population 
(Adamson et al., 2006). Vinca alkaloid drugs function by binding to tubulin, which is a 
major component of micortubules. The development of microtubules is thus interrupted, 
affecting various cell functions, including mitosis, the movement of such solutes as 
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neurotransmitters and hormones, and the cell structure itself (Adamson et al., 2006). 
Types of vinca alkaloids include vincristine, vinblastine, and vinorelbine.  
Vincristine is widely used in combination therapy for ALL treatment, as well as 
being involved in the treatment for neuroblastomas, brain tumors, and lymphomas. 
Vincristine doses typically range between 1.0 to 2.0 m² and are administered via IV 
every one to three weeks (Adamson et al., 2006). Side-effects may include peripheral 
neuropathy, neurotoxicity, cranial motor nerve effects, nausea, inappropriate 
antidiuretic hormone syndrome, and seizures (Adamson et al., 2006).  
Vinblastine is often used to treat lymphomas and testicular cancer. Typically 
administered in one to three week cycles, doses range between 3.5 to 6.0 mg per m² 
(Adamson et al., 2006). Vinorelbine is the newest vinca alkaloid drug and has good 
implications for acute leukemias and chronic myelogenous lymphoma. It is administered 
via infusion weekly at 30 mg per m² doses for up to six weeks (Adamson et al., 2006).  
The epipodophyllotoxins, including etoposide and tenoposide, are responsible for 
DNA strand breaks. This drug classification may be administered to children with 
leukemia, neuroblastomas, brain tumors, and lymphomas (Adamson et al., 2006). 
Administration of these drugs is usually over three days, at doses of 60 to 120 mg per 
m² per day for etoposide and 70 to 80 per m² per day for teniposide. These 
chemotherapy agents may also be used preoperatively for bone marrow transplants 
(Adamson et al., 2006). 
The taxanes drugs function by interfering with microtubule functioning, 
eventually leading to cell apoptosis. Paclitaxel and docetaxel, which are used often in 
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adult cancer treatment regimens, are not necessarily appropriate for pediatric regimens. 
Camptothecins, including topotecan and irinotecan, alter cell development by causing 
breaks in the DNA strands. Topotecan may be used to treat neuroblastomas or 
rhabdomysarcomas at daily doses of 1.4 to 4.5 mg via IV or oral administration. 
Irinitecan may be used to treat neuroblastomas, rhabdomyosarcoma, and various CNS 
tumors (Adamson et al., 2006). However, irinitecans utility in pediatric treatment is 
undetermined.  
Additional Physical side-effects of Chemotherapy 
Drug treatments may result in hair loss, weight gain or loss, fatigue, constipation, 
low blood counts, and temporary problems with peripheral nervous system functioning 
(Copeland, Dowell, Fletcher, Sullivan, Jaffe, Cangir, et al., 1988; Margolin & Poplack, 
1997). Early side effects at the completion of therapy may include increased 
susceptibility to infection, low blood counts, nausea, loss of appetite, hair loss, 
neuropathy, sensitivity to sunburn, and constipation or diarrhea (Shenoy, n.d.).  
Radiation Therapy 
Radiation therapy may be considered for children with brain tumors after surgical 
approaches have been ruled out. It is often given to children with CNS tumors, either 
locally to the tumor site or to the entire brain and spinal cord (Anderson et al., 2001), 
ranging between 30 gray radiation (Gy) doses to 60 Gy doses. In children with ALL, 
doses are generally around 18 to 24 Gy (Anderson et al., 2001).  
Types of Radiation Therapy  
Conventional external beam radiotherapy. 
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Conventional radiotherapy employs constant dose intensity across the radiation 
field (Tarbell et al., 2006). This technique exposes everything in the path of the 
radiation ray (Tomita, 2000). This technique is often performed while the child is 
outpatient and is delivered five days a week for five to six weeks (Tomita, 2000). The 
most common disadvantage to conventional radiotherapy is the inclusion of normal 
brain tissue in exposure to radiation agents. Tumors may reoccur in the irradiated area 
years later (Tomita, 2000). 
Focal Radiotherapy (also known as Conformal Radiation). 
Focal radiotherapy aims to direct radiation doses to the tumor, with minimal 
exposure to surrounding healthy tissue. Thus, focal radiotherapy results in less toxicity 
and lower long-term side-effects, superior to conventional radiotherapy (Ater et al., 
2005). M.D. Anderson uses computed tomography (CT) scans at 3mm slices to obtain 
the precise location of the childs tumor, outlining the tumor and normal tissue for 
determination of the gross tumor volume (GTV; Ater et al., 2005). If the tumor cannot 
be viewed clearly with CT scans, higher sensitivity magnetic resonance imaging (MRI) 
scans can supplement CT scans. In addition to the GTV, the clinical target volume 
(CTV) must also be determined, especially for malignant tumors, to estimate the 
number of tumor cells undetected by CT and MRI scans (Ater et al., 2005). Then, the 
planning target volume is calculated to account for any possible patient movement and 
to determine the best placement of the radiation beam to maximize exposure to the 
tumor and minimize exposure to normal structures (Ater et al., 2005). 
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Intensity-modulated radiotherapy (IMRT) and three-dimensional radiotherapy 
(3DRT) are two different focal radiotherapy techniques. In both techniques, children are 
immobilized, CT scans are used, and the GTV and CTV are calculated to prescribe the 
correct radiation dose (Ater et al., 2005). In 3DRT, several beams from multiple angles, 
useful for smaller tumor volumes, target the tumor. With 3DRT, 30% less of normal 
tissue is affected as compared to conventional radiotherapy (Blaney et al., 2006).  
IMRT is indicated for more irregularly shaped tumors and tumors near critical 
structures. In IMRT, the computer assigns different radiation beams specific doses and 
intensities, thus making the beams heterogeneous (Ater et al, 2005). The tumor is 
subdivided into units, with each unit possibly being targeted by radiation beams 
individually, increasing the amount of the radiation dose hitting its target (The 
Cleveland Clinic, 2003). 
Craniospinal radiotherapy (CSRT). 
CSRT has been largely used for tumors that have spread through the CSF, such 
as medulloblastomas, supratentorial PNETs, and aggressive embroyonal tumors (Ater et 
al., 2005). Due to the need for larger radiation doses to target these tumors, this 
technique has decreased in popularity because of the increased risk for long-term side-
effects. To begin, the child is immobilized and has a CT scan taken of their head and 
spine. Then, the reference points are determined in the brain and spine. An unfortunate 
side-effect is radiation exposure to the lens of the eyes, possibly causing cataracts (Ater 




Stereotactic radiotherapy, either as single-fraction or multiple-fraction 
radiosurgery, focuses a large number of narrow beams of high dose radiation, via x-ray 
or gamma-knife, to a focal point (Tarbell, Yock, & Kooy, 2006). Stereotactic frames are 
used to position patients, imaging their anatomy, and determining the intended 
direction of the radiation beams (Tarbell et al., 2006). The radiation doses are delivered 
via continuously rotating beams over several intervals and positions. This technique is 
often used to reinforce the effects of conventional radiotherapy and for recurrent brain 
tumors. In single-fraction stereotactic radiosurgery, the patient comes for one day of 
treatment, in which the stereotactic frame is rigidly fixed to the patient. Thus, they 
receive one large radiation dose (Tomita, 2000). In multiple-fraction stereotactic 
radiotherapy, the patient is treated over multiple days and receives a retractable, 
noninvasive stereotactic frame. This technique is ideal for small brain tumors that are 
noninvasive and radiographically distinct (Tarbell et al., 2006). 
Internal radiation therapy (brachytherapy). 
Brachytherapy involves inserting a catheter implant either in a body cavity 
(intracavity implants) or into tissue in or near the tumor (interstitial implants). 
Regardless of the technique used, radiation doses are targeted to the cancer tissue, 
while healthy tissue is relatively spared (Tarbell, et al., 2006). These implants are 
removed typically in four days after the radiation dose has been delivered to the tumor 
(Tomita, 2000). The most frequently used radionuclides, which break down by emitting 
gamma rays (Venes, 2001), include Iridium-192 and iodine-125, which deliver radiation 
doses continuously while the implant is inserted. This treatment modality has been used 
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often for pediatric malignancies, including retinoblastoma (Tarbell et al., 2006). Since 
this technique delivers the radiation dose to a specific location, large and malignant 
tumors are not good candidates for this radiotherapy method. 
Late Reactions to Radiation Therapy  
Late-effects may not surface until years post-treatment and are related to the 
dose and fraction size (Tarbell et al., 2006). Duffner (2004) cited an association 
between radiation therapy and significant cognitive and growth impairments, 
particularly in younger children and at higher doses. Children less than three years are 
most affected (Shenoy, n.d.). Late side-effects of radiation to the brain may affect 
movement, coordination, intelligence, hormone production, irritation or drying of the 
eyes, and cataracts. Additional side-effects may include stone formation in the salivary 
glands, dental problems, food malabsorption, thyroid change (weight gain, cold 
intolerance), defective heart or lung functioning, decreased functioning of the adrenal 
gland, and slowed bone growth (Shenoy, n.d.). Also, radiation therapy may increase the 
risk for the development of a secondary cancer, especially in the previously radiated site 
(Shenoy, n.d.). Warring and Wallace (2000) reported that radiation could damage both 
the testes and ovaries.  
Bone Marrow Transplant (BMT) 
BMT is a treatment option when its believed other treatments would not 
realistically result in long-term survival with no reoccurrence of the disease. BMT is also 
a treatment option for myelosuppression, which results from chemotherapy treatment 
(Guinan, Krance, & Lehmann, 2002). That is, devastating side-effects of cancer 
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treatment, either chemotherapy or radiation therapy, include the demise of healthy cells, 
including hematopoietic stem cells, and the interference with the bone marrows ability 
to manufacture blood cells. Hematopoietic stem cells reside in the bone marrow and 
either divide to become more stem cells, or they mature to become white blood cells 
(WBCs), red blood cells (RBCs), or platelets, which are essential to healthy immune 
functioning (National Cancer Institute, 2004). Bone marrow is particularly affected by 
cancer treatment because its role is to continuously produce new blood cells and 
facilitate cell division (Kurtzberg & Clements, 2006). Therefore, BMT replaces these 
stem cells that were destroyed by previous treatment (National Cancer Institute, 2004).  
 Highly sensitive assays are run to determine histocompatibity between the donor 
and the recipient. These assays identify the human leukocyte-associated antigens (HLA; 
Guinan et al., 2002), proteins on cells used to determine compatibility between donor 
and recipient. The risk for graft- versus- host disease (GVHD) is reduced when the HLA-
match is close. That is, identical twins have the same HLA code, therefore the risk of 
GVHD in minimal. Between 25 and 30% of candidates for BMT have a sibling with the 
same HLA-matched code. For unrelated donors, the chance of finding a HLA-matched 
donor jumps to 50% (National Cancer Institute, 2004). 
Conditioning Phase 
After histocompatibility is determined, the conditioning phase commences.  This 
conditioning regimen serves several purposes, including removing any residual tumor 
cells and suppressing the hosts immune system to reduce the likelihood that donor 
cells will be rejected. This creates physical space for the donated stems cells to reside 
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upon transplantation (Guinan et al., 2002). Another function of the conditioning phase 
is preparation of the stem cells for infusion. This stage includes depleting t-cells from 
the donor cells in order to reduce the risk for GVHD, removing any malignant cells from 
the donor stem cells, and reducing the number the red cells (Guinan et al., 2002).  
Two weeks prior to transplant, patients are treated with total- body irradiation 
(TBI) or busulfan (BU), the mainstay of the conditioning phase. However, these 
treatment regimens vary depending on the disease being treated. Consequently, prior 
to transplant, these children are exposed to the side-effects of radiation and 
chemotherapy, with which the effects may endure up to three months post-transplant 
(Kurtzberg & Clements, 2006). 
Types of Transplants 
 Autologous transplant. 
 Autologous transplants involve harvesting stem cells from the patient's own bone 
marrow or peripheral blood (Guinan et al., 2002). Potential contamination of the sample 
with residual tumor cells is a foremost limitation of autologous transplants. Graft failure 
may result if the transplanted stem cells are damaged during transplantation or if they 
fail to kill damaged stem cells existing in the bone marrow (Guinan et al., 2002). While 
autologous transplants have low overall mortality rate (usually 10% or less), the risk for 
relapse is quite high, ranging up to 72% (Guinan et al., 2002). 
 Syngenic transplant. 
 Syngenic transplants harvest stem cells from an identical twin sibling. Stem cells 
in identical twins are the same, thus are ideal for transplants. GVHD is not a risk factor 
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in syngenic transplants. For unknown reasons, patients that have syngenic transplants 
are at an increased risk for cancer relapse. Therefore, the survival rate is comparable to 
autologous and allogenic transplants (Efiom-Ekaha, Patel, Kuku, & Ladapo, 2004). 
Overall, the likelihood of having identical twins is quite rare (Guinan et al., 2002).   
 Allogenic transplant. 
 Allogenic transplants harvest stem cells from donors with an identical HLA code, 
either from family members, unrelated donors, or from mismatched family members 
(Guinan et al., 2002). In the United States, children are often donors because they have 
higher concentrations of stem cells in their bone marrow and peripheral blood (Guinan 
et al., 2002). Also, people may volunteer to donate, assuming they are between the 
ages of 18 and 60 and meet the health requirements. Bone marrow is cryopreserved 
through programs such as the National Marrow Donor Program until needed (Guinan et 
al., 2002).   
 In children with ALL with HLA- identical donors, 39% survived disease free, while 
30% survived disease free with HLA-mismatched donors (Gluckman, Rocha, & Chastang, 
1998). Overall, while disease free survival is decreased with HLA-mismatched donors, 
these observed differences are diminishing with improvements in the assays used to 
determine HLA-match (Guinan et al., 2002).   
Complications Resulting from BMT 
 Graft Versus Host Disease (GVHD). 
 When the transplanted donor stem cells (graft) are recognized by the host cells 
as foreign and are subsequently attacked, GVHD results. The organs most often 
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affected include the skin, the liver, and the gastrointestinal system. Therefore, common 
conditions resulting from GVHD include dermatitis, hepatitis, and enteris (Guinan et al., 
2002). GVHD can be classified as acute, occurring within a few weeks of the transplant, 
or chronic, with side-effects surfacing a significant amount of time after the transplant 
(National Cancer Institute, 2004).  
 Additional side-effects of BMT. 
 Patients may be more susceptible to infections from prolonged myelosuppression 
resulting from the BMT procedure. Children may be placed at a heightened risk for 
secondary malignancies, particularly after autologous transplants (Guinan et al., 2002). 
Endocrine complications may result, as well as gonad and ovarian failure. Thyroid 
dysfunction, growth failure, cataracts, renal disturbance, and decreased lacrimation are 
potential consequences from BMTs (Guinan et al., 2002).  
 Graft failure is also a possible side- effect. The incidence of graft failure for 
syngenic transplants is around 1%. For mismatched donors and autologous transplants, 
the likelihood of graft failure rises to 5 to 10%. Disease relapse is the biggest 
contributor to graft failure (Guinan et al., 2002).   
Additional Treatment Regimens 
Corticosteroids may be used in treatment for pediatric brain tumors, ALL, 
lymphomas, and Hodgkins disease. They may also be used to treat the side-effects of 
cancer and cancer treatment. Corticosteroids, including prednisone, dexamethasone, 
and prednisolone, cause receptor-mediated lympholysis by binding to glucocorticoid 
receptors (Adamson et al., 2006). Dexamethasone is also used to reduce cerebral 
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edema around the tumor (Tomita, 2000). Dexamethasone therapy may put children 
treated for ALL at risk for neurocognitive late effects compared to children treated with 
prednisone (Waber, Caprentieri, Klar, Silverman, Schwenn, Hurwitz, et al., 2000). 
Common side-effects include increased appetite, immunosuppression, hypertension, 
and amenorrhea (Adamson et al., 2006). The uses of steroids for long periods may 
cause cataracts, weight gain, excess hair growth, steroid dependency, high blood 
pressure, and diabetes (Shenoy, n.d.; Tomita, 2000). Furthermore, the adrenal glands 
that normally produce natural steroids in the body may stop functioning properly. 
Psychiatric side-effects may include hypomania, mood swings, sleep difficulties, anxiety, 
and personality changes (Brown, 1998).  
Asparaginase is an enzyme derived from the bacterium escherichia coli or erwina 
cartovora commonly used for nutritional treatment for ALL and lymphomas (Beers & 
Berkow, 1999). Asparagine is an amino acid found in the body that is essential for 
protein synthesis. It functions by depleting asparagine in the blood. Typically, when 
normal cells detect decreased amounts of asparagine in the body, they are able to 
produce more. However, cancer cells are unable to produce more, so they die. 
Asparaginase is administered either through IV or intramuscularly in doses of 6,000 to 
25,000 IU per m² three times a week (Blaney, Holcenberg, & Blaney, 2001). Side-
effects may include reactions to the bacteria, encephalopathy, clotting of the blood, 
pancreatitis, or liver damage (Adamson et al., 2006). 




Pediatric cancer survivors often exhibit significantly lower performance 
intelligence quotients (PIQs) and verbal intelligence quotients (VIQs) on the Wechsler 
scales than their healthy peers (Winqvist, Vainionpaa, Kokkonen, & Lanning, 2001). 
Brain tumor survivors under the age of 18 exhibited mild cognitive impairment. 
Survivors demonstrated more difficulties with nonverbal tasks, averaging a mean 
difference of 7.3 points (Poggi, Liscio, Galbiati, Adduci, Massimino, Gandola, et al., 
2005). Children with ALL who underwent radiation therapy with chemotherapy scored 
8.7 points lower on full-scale intelligence quotient (FSIQ) than children treated with 
chemotherapy alone (Langer, Martus, Ottensmeier, Hetzberg, Beck, & Meier, 2002). 
Attention and Concentration 
The most profound neurocognitive deficits that have been documented in 
pediatric cancer survivors involve attention and concentration abilities (Mulhern & Butler, 
2004). Peckham (1991) conducted a longitudinal study of 18 children treated with 
2,400 centi-Gray units (cGY) prophylactic cranial irritation eight to ten years previously. 
Therefore, pre and post-treatment intellectual abilities were collected. Visits were made 
to the childs school, teachers were consulted, parents were interviewed, and children 
were observed in class and interviewed (when possible). The most frequent problem 
cited by all sources was with attention and concentration, specifically inner distractibility. 
Memory 
Memory is another domain of neurocognitive functioning affected by childhood 
cancer treatment. Memory difficulties have been reported in 50-75% of children with 
brain tumors (Armstrong et al., 1999). Children with ALL are at increased risk for short-
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term memory loss (Dennis, Spiegler, Hoffman, Hendrick, Humphreys, & Becker, 1991). 
For survivors of ALL, deficits in nonverbal memory and attention were significantly 
related to deficits in general intelligence, neurocognitive problems, and delays in 
academic achievement (Moleski, 2000). 
Brouwers and Poplack (1990) evaluated verbal memory, nonverbal memory and 
learning in 23 survivors of ALL treated via cranial irradiation or intrathecal 
chemotherapy off-treatment for at least four years. Subjects were classified into one of 
three groups based on their CT scans: normal scans, cerebral atrophy, or intracerebral 
calcifications. Participants with intracerebral calcifications demonstrated greater 
information loss and more problems with verbal learning than the other two groups. 
When evaluating the effect of mean reaction time on learning and memory 
performances for group differences, analyses demonstrated group differences 
decreased when adjusting for attentional deficits. Authors concluded that attention 
abilities are mediating the memory and learning deficits presented in subjects, 
influencing the encoding of information. 
Visual-Motor Integration and Motor Abilities 
Visual-motor integration problems and slowing in processing speed have been 
noted in children with brain tumors (Coniglio & Blackman, 1995; Winqvist et al. 2001). 
Fine-motor skills and perceptual-motor skills may be negatively affected as a result of 
CNS chemotherapy, at least in the acute phase of treatment (Moleski, 2000). Kieffer-
Renauz, Bulteau, Grill, Kalifa, Viguier, and Jambaque (2000) found that survivors of 
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medulloblastomas demonstrate deficits in visuo-constructive skills and manual dexterity, 
regardless of the strength of radiation dose.  
Wright, Halton, Martin, and Barr (1998) studied the motor performance in 36 
child survivors of ALL, comparing them to 26 age and gender matched controls. Results 
found that gross motor tasks that required balance, such as hopping on one foot and 
jumping, were more problematic for survivors. Hand grip strength, running speed, and 
agility, were also compromised when compared to controls. Motor impairments were 
hypothesized to be a side-effect of chemotherapeutic agents, cranial irradiation, and 
steroids.  
Previous Research Regarding Psychosocial Functioning  
Several areas of psychosocial functioning have been researched in pediatric 
cancer survivors, including internalizing behaviors, externalizing behaviors, self-image, 
social functioning, and academic functioning. Throughout the literature, there are 
discrepancies in findings.  
Internalizing Behaviors 
The research is mixed as to the effect of childhood cancer on survivors mood. 
More specifically, internalizing behaviors, ranging from depression, anxiety, poor self-
image, social withdrawal, and somatic complaints, have been inconsistently reported in 
children with cancer.  
Depression 
On one side, researchers state that the child survivors feelings of control are the 
factors that ultimately determine their insecurity or confidence. If these children do not 
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feel a sense of control, they may experience feelings of hopelessness (Last & 
Grootenhuis, 1998). Chao, Chen, Wang, Wu, and Yeh (2003) administered a depression 
inventory to 24 pairs of children with cancer and their parents. The participants and 
their parents completed a psychosocial adjustment questionnaire containing items 
regarding demographics, psychosocial health characteristics, perception and attribution 
of the illness, and psychological functioning of the family. Results indicated the children 
did not rate themselves as having more social, academic difficulties, or depressive 
symptoms as compared to grade and gender equivalent norms. However, their parents 
rated them to have more mood disturbances and fewer friends.  
Lavigne and Faier-Routman (1992) conducted a meta-analysis of 28 studies, 
concluding that children with chronic illnesses are at risk for adjustment difficulties. 
Moreover, survivors are at risk for internalizing behaviors, such as depression or anxiety, 
opposed to externalizing problems, such as aggression. However, Lavigne and Faier-
Routman cautioned that the results from the meta-analysis are dependent on the 
methodology used in the included studies. 
Kunin, Patenaude, and Grier (1995) discovered ten documented or suspected 
suicide attempts between 1974 and 1991 at the Dana-Farber Cancer Institute. These 
ten attempts included two successful suicides, four attempts, two deaths from 
undetermined causes, and two deaths potentially resulting from reckless behavior. 
Researchers concluded that, in some children, the diagnosis of cancer may, place an 
additional, unmanageable demand on already burdened coping resources (p.153). 
They discussed several factors that may contribute to increased suicide risk in this 
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population, including depression and hopelessness, stressful family events, preexisting 
psychopathology (e.g. substance abuse), loss of control or helplessness, prior suicide 
history, interpersonal isolation, advanced illness or poor prognosis, and pain 
management difficulties. They cautioned, however, these numbers may be an 
underestimation because of the reluctance of health care professionals and families to 
divulge such information. However, authors concluded the suicide risk for pediatric 
cancer survivors is similar to those of the general population of children and 
adolescents.  
A higher prevalence of depression has been suspected in children with cancer for 
two reasons: Depression has been documented as common in children with chronic 
illnesses and is common in adults with cancer (Eiser, 2004). Bennett (1994) conducted 
a meta-analysis of 60 studies, concluding that children with physical illnesses are at an 
increased risk for depressive symptomatology, but do not necessarily meet the criteria 
for clinical depression. Bennett remarked that parents seemed to endorse more 
depressive symptoms in their children than children do themselves. Phipps and 
Sprivastava (1997) suggested that patients rate themselves as having less 
psychopathology because they tend to adopt a protective coping bias to minimize stress. 
Children with asthma, recurrent abdominal pain, and sickle cell anemia reported more 
depression than did children with cancer and diabetes. 
Anxiety 
Eiser, Hill, and Vance (2000) conducted an analysis of twenty studies in English 
published since 1990, comparing survivors to matched controls or population norms. 
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After surveying these studies, they concluded that survivors do not exhibit greater 
levels of anxiety than others. In fact, many studies have revealed survivors to have a 
positive outlook toward their past encounter with cancer (Eiser et al., 2000; Zebrack & 
Chesler, 2002).  
Zebrack and Chesler (2002) studied 176 survivors successfully off treatment. 
Information was gathered from medical charts and a self-report questionnaire to 
measure quality of life. Survivors reported a healthy ability to cope after their cancer 
experience, suggesting a resiliency in young survivors against the negative effects of 
cancer and its treatment.  
Hormone levels were checked in children with cancer both on and off treatment 
on two separate clinic visits (Hockenberry-Eaton, Kemp, & Dilorio, 1994). Physiologically, 
children had higher epinephrine levels than expected, suggesting they were 
experiencing a chronic state of stress. Yet, this can be misleading, since their cortisol 
and norepinephrine levels were still within normal limits. 
Self-image 
The cancer experience can adversely affect childrens perceived sense of 
attractiveness, as treatment side-effects may include changes in weight, the loss of hair, 
or skin changes (Eiser, 2004). Onset of cancer during adolescence may cause more 
distress for the patient compared to early or late onset (Eiser, 2004). Adolescent 
survivors of cancer may be at increased risk for eating disorders as a result of the side-
effects of treatment, including weight gain, interference of normal development, and 
scarring (Rodin, Daneman, & deGroot, 1993). 
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Coniglio and Blackman (1995) reported that survivors endorse poorer self-
concepts compared to their peers. Also, survivors have been shown to have poorer self-
image by reason of changes in their physical appearance (Armstrong et al., 1999; 
Zebrack & Chesler, 2002). Noll, Gartstein, Vannatta, Correll, Bukowski, and Davies 
(1999) reported that children with cancer have lower self-confidence in their athletic 
abilities, perhaps due to reduced energy levels or chronic fatigue. Furthermore, 
Willoughby, Polatajko, and Wilson (1995) reported that childrens motor abilities 
contribute to their self-esteem, success in therapeutic recreation activities, and overall 
level of fitness.  
In contrast to the studies previously discussed, Maggiolini, Grassi, Adamoli, 
Corbetta, Charmet, Provantini, et al. (2000) studied self-image in Italian adolescent 
survivors of ALL. Seventy former patients between the ages of 12 and 20 who had 
completed therapy at least two years prior were compared to 70 secondary students 
similar in age and geographic area of residence. Results indicated that adolescent 
survivors of ALL demonstrate more emotional stability, better self-image and body 
image, more confidence and socially support, and a general positive attitude compared 
to their peers. 
Zebrack and Chesler (2002) found that childhood cancer survivors endorse a 
positive quality of life and rate themselves as being able to effectively cope with their 
illness. Overall, the major predictor of positive emotional outcomes in children with 
cancer is positive expectations of the future (Last & Grootenhuis, 1998). Elkin, Phipps, 
Mulhern, and Fairclough (1997) found pediatric cancer survivors report greater 
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psychological health and well- being, as well as lower psychological distress than would 
be expected based on healthy controls. While 75% showed some residual cosmetic 
impairments and 64% had some physical impairments, survivors indicated they were 
functioning psychologically better than expected.  
Externalizing Behaviors 
The research on externalizing behaviors in pediatric cancer survivors, such as 
aggression and substance abuse, is also mixed. Although many of the studies have 
found that children with brain tumors are not at risk for significant externalizing 
problems, Rynard, Chambers, Klinck, and Gray (1998) administered the Child Behavior 
Checklist (CBCL; Thomas Achenbach, www.aseba.org/products/cbcl6-18.html) and 
Behavior Assessment System for Children (BASC) Teacher Report Form (TRF; AGS 
Publishing, www.agsnet.com) to teenagers on-treatment or recently off-treatment 
reentering school. While parents rated their survivors to be more aggressive and 
hyperactive than their teachers, survivors did not demonstrate significant externalizing 
behavioral problems (Fuemmeler et al., 2002). Mulhern, Carpentieri, Shema, Stone, and 
Fairclough (1993) revealed several factors relating to elevated behavior problems in 
children with brain tumors compared to children with other forms of cancer, including: 
younger maternal age at childs birth, tumor location, and living in a single-parent home.  
Mulhern et al. (1993) reported that both the brain tumor and cancer control 
groups demonstrated similar low levels of social competence and high levels of behavior 
problems soon after diagnosis. Verrill, Schafer, Vannatta, and Noll (2000) found that 
young adult cancer survivors report less illegal drug use and experimentation, 
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concluding that the cancer experience may be protective against the development of 
externalizing behaviors.  
Social Functioning 
The literature concerning the social functioning in pediatric cancer survivors is 
mixed. Mackie, Hill, Kondryn, and McNally (2000) administered the Adolescent to Adult 
Personality Functioning Assessment (AFBA; Naughton, Oppenheim, & Hill, 1996) to 
assess social role performance and interpersonal relationships in long-term survivors of 
childhood cancer. Researchers found that adult survivors of childhood ALL 
demonstrated significantly more difficulties in close relationships. Compared to a group 
of children from pediatric hospitals, 40% of adult survivors of childhood ALL report 
being teased about their physical appearance and being treated like outcasts (Kazak, 
Barakat, Meeske, Christakis, Meadows, Casey, et al., 1997).  
Butler, Rizzi, & Bandilla (2000) found that over 80% of their sample childhood 
cancer patients on and off treatment between the ages of 6 and 16 did not meet 
criteria for significant psychological and adjustment disturbance. Results showed that, 
as time passed since the first cancer treatment, social incompetence and social skill 
deficits were more likely to emerge. In the circumstances that psychological difficulties 
were present, they were more likely to be the result of some situational aspect of the 
cancer or its treatment. Hill, Kondryn, Mackie, McNally, and Eden (2003) studied 102 
adult survivors of childhood ALL or Wilms tumors and 102 matched controls via 
standardized interview methods, finding survivors have poorer day-to-day coping 
abilities and close adult relationships than controls.  
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Boman and Bodegard (1995) reported that survivors experience impaired social 
functioning. Spirito, DeLawyer, and Stark (1991) found that their social interactions may 
suffer due to observable physical differences. Survivors have been rated by their peers 
to be more socially isolated, withdrawn and have fewer peer friends (Noll, Bukowski, 
Davies, Koontz, & Kulkarni, 1993; Spirito, Stark, Cobiella, Drigan, Androkites, & Hewitt, 
1990).  
Hill et al. (2003) found that adult survivors of childhood cancer are more likely to 
have impaired close relationships, both romantic relationships and friendships. Hays, 
Landsverk, Sallan, Hewitt, Patenaude, Schoonover, et al. (1992) found a decreased 
number of marriages or cohabitation relationships among pediatric cancer survivors, 
suggesting survivors may have difficulties with intimacy and increased interpersonal 
isolation. While Novakovic, Fears, Wexler, McMlure, Wilson, McCala, et al. (1996) 
reported that survivors show lower marriage rates and higher divorce rates compared 
to siblings and population norms, Hays et al. (1992) found no difference in divorce rates 
compared to population norms. 
La Greca (1990) emphasized the difficulty of survivors returning to school, in that 
they may be dealing with teasing from their peers, as well as harboring feelings that 
they are different and unattractive. Eiser (2004) posited teasing and social isolation may 
be even more upsetting than the physical pain associated with the illness and diagnostic 
procedures.  
BMT survivors have also been reported to have more difficulties socially. 
Vannatta, Zeller, Noll, and Koontz (1998) found that peers rated BMT survivors as 
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having fewer friends, being more socially isolated, and being less physically attractive. 
Phipps (2005) found that their social competence, self-esteem, and emotional well- 
being declined between six months to one year post treatment.  
On the other hand, Zebrack and Chesler (2002) found that childhood cancer 
survivors report a high level of satisfaction in their social relationships. Newby, Brown, 
Pawletko, Gold, and Whitt (2000) found no significant social skills deficits in 42 children 
and adolescent cancer survivors participating in a late-effects follow-up clinic. Parents 
rated poor adjustment in 14% of the sample, while teachers rated poor adjustment in 
only 7% of the sample. Elkin, Tyc, Hudson, and Crom (1998) found that over half of 
their sample of long-term survivors participated in organized sports. Of those that did 
not participate, 64% said they had no difficulties competing with their peers.   
van Dongen-Melman and Saunders-Woudstra (1986) reported that any 
adjustment problems experienced by survivors are transient and mild. School phobias in 
this population are very rare (Landsky, Lowman, Vats, & Gyulay, 1975). In fact, studies 
have shown that survivors typically recount their cancer experience as a positive 
experience (Eiser et al., 2000; Zebrack & Chesler, 2002).  
Mediating Variables to Social Functioning 
Several studies have addressed contributing factors to social obstacles in 
survivors. Mulhern et al. (1993) found a relationship between social problems and overt 
functional status in child and adolescent patients recently diagnosed with cancer, 
especially in cases when severe debilitation was present. Zebrack and Chesler (2002) 
found social quality of life to be related to survivors physical health and their living 
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situation (alone or with others), suggesting interdependency between physical, social, 
and psychological variables.  
Parental encouragement has been posited to be a contributing factor as well. For 
female survivors, the lack of encouragement from parents and high levels of maternal 
involvement were positively associated with poor adult relationships (Hill et al., 2003). 
However, the authors stated that parental encouragement does not appear to be the 
major mediator between cancer survivorship and adult functioning. 
Also, research suggests that children with brain tumors have an increased 
probability of developing social competency deficits as compared to their peers with 
non- CNS tumors and healthy peers (Fuemmeler et al., 2002). Mulhern et al. (1993) 
found the children with brain tumors in their study demonstrated slightly more 
problems with social competence, participation in activities, and school performance 
than the cancer control group. 
Finally, another contributing variable is the age of the survivor. Age appears to 
have an increasing detrimental effect on psychosocial functioning. Adolescents may 
experience more limitations in social functioning, as they may be forced to rely on their 
parents and be isolated from their friends because of their condition. Therefore, 
adolescents with cancer face obstacles in achieving a developmentally appropriate 
sense of identity and intimacy (Eiser, 2004).  
Academic Functioning 
As a result of cancer and/or its treatment, more than half of children diagnosed 
with leukemia or a brain tumor will be at risk for a learning impairment (Armstrong & 
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Mulhern, 1999). Madan-Swain, Brown, Walco, Cherrick, Ievers, Conte, et al. (1998) 
found that more than one-third of survivors received special education services part-
time, while 7% required full-time services. However, only 8% of their sample met the 
criteria for a learning disability, while the remaining participants received services based 
solely on their medical condition. Studies have found that between 26 and 47% of 
pediatric cancer survivors have repeated a grade (Moore, Glasser, & Albin, 1987; 
Mulhern, Waserman, Friedman, & Fairclough, 1989).  
Hays, Dolgin, Steele, Patenaude, Hewitt, Ruymann, et al. (1997) conducted 
phone interviews of 300 cancer survivors ages 20 or older. Researchers discovered that 
survivors completed fewer years of school, had higher rates of unemployment, lower 
occupational status, and lower annual incomes compared to matched controls.  
Demographic and Treatment Factors Mediating Neurocognitive Functioning and 
Psychosocial Functioning  
There are many mediating effects involved in the effects of cancer and its 
treatment. The diagnosis and elements of the treatment may modify the psychosocial 
and neurocognitive presentation of survivors of pediatric cancer. Furthermore, age at 
diagnosis and gender may influence the effect of cancer and its treatment on 
psychological and neurocognitive functioning of survivors.  
Diagnosis 
Diseases that involve the CNS and bone tumors have been associated with more 
adjustment difficulties (Boman & Bodegard, 2000; Langeveld, Stam, Grootenhuis, & 
Last, 2002). Brain damage can result from brain tumors, effects of treatment, and 
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comorbid conditions, such as seizures and hydrocephalus (Mulhern, Hancock, Fairclough, 
& Kun, 1992). Manne and Miller (1998) found the single most crucial predictor of 
psychological adjustment in adolescents with cancer was physical impairment. 
Children with CNS tumors reported significantly more quality of life difficulties 
compared to children with ALL and normal population means (Eiser, Greco, Vance, 
Horne, & Glaser, 2004). Furthermore, children with CNS tumors endorsed more 
discrepancies between what they would like to do and what they are able to do, 
especially regarding their physical functioning. Brain-damaged children are at three 
times the risk for psychological maladjustment compared children with chronic illness 
with no CNS involvement (Rutter, Graham, & Yule, 1970). Survivors of brain tumors are 
at increased risk for more severe deficits based on the more aggressive nature of their 
treatment (Butler & Copeland, 1993). 
Type of Treatment 
The type of treatment has been found to effect cognitive and psychological 
functioning. A loss of opportunity to learn, due to multiple clinic visits and side effects of 
treatment, may lead to learning problems in survivors. 
Chemotherapy  
On one hand, Copeland, Moore, Jaffe, and Culbert (1996) longitudinally studied 
51 children with cancer who received ITC and 48 who received non-CNS treatments 
(NITC). Neuropsychological assessments included measures of intelligence, 
achievement, language, memory, distractibility, executive planning, fine-motor abilities, 
perceptual motor abilities, and tactile-spatial skills. Results indicated that the effects of 
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chemotherapy are minimal with the exception that children treated with ITC 
demonstrated more perceptual-motor deficits than children treated with NITC at three 
year and long-term follow-up evaluations. However, their performances were still in the 
average range.  
On the other hand, children treated via ITC are at risk for developing nonverbal 
learning difficulties, potentially requiring special education services (Armstrong, 
Blumberg, & Toledano, 1999). Also, more intensive chemotherapy has been associated 
with more adjustment problems (Zebrack & Zeltzer, 2003). Moleski (2000) addressed a 
misconception that CNS chemotherapy treatment is safer than CRT. After reviewing 
available literature, Moleski concluded that CNS chemotherapy is harmful, cautioning 
that the late-effects are still largely unknown. All in all, cancers that require more 
aggressive treatment place children at an increased risk for cognitive problems 
(Winqvist et al., 2001; Armstrong et al., 1999; Fuemmeler et al., 2002).  
Radiation Therapy 
Within the neurocognitive domain, areas that may be affected by CRT include 
short-term memory, attention, fine motor coordination, visuospatial abilities, and 
somatosensory abilities (Lottick & Neglia, 2005). Nearly all children with brain tumors 
that are treated with high doses of CRT will need ongoing special education services. 
On one hand, Rubenstein et al. (1990) found that cognitive profiles in survivors of ALL 
were similar, regardless if they were treated with 1800 cGy or 2400 cGy of CRT. 
Therefore, findings suggest that the impact of CRT is an all-or-none phenomenon, 
opposed to a dose-dependent effect (Butler et al., 1994). On the other hand, Kieffer-
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Renauz, et al. (2000) studied 36 survivors of medulloblastomas treated with radiation 
doses of either 25 Gy or 35 Gy. Results indicated that survivors treated with 25 Gy 
doses demonstrated higher overall intelligence, concluding that there is a negative 
correlation between strength of radiation dose and intelligence. Overall, chemotherapy 
drugs are preferential over radiation therapy for younger children, since the effects are 
greatest for younger children (Ulrich & Pomeroy, 2003). 
Combination Therapy 
Reimers, Ehrenfels, Mortensen, Schmiegelow, Sonderkaer, Carstensen et al. 
(2003) studied 133 adult survivors of childhood brain tumors treated with resection, 
chemotherapy, radiation therapy, or a combination of the three. Results indicated 
radiation therapy to be the most important predictor for cognitive deficits, as well as 
hydrocephalus, history of having a shunt, having a cerebral hemisphere tumor, and 
younger age at diagnosis. 
Butler, Hill, Steinherz, Meyers, and Finlay (1994) studied the neuropsychological 
after-effects of CRT, intrathecal methotrexate (IT-MTX), and systemic methotrexate 
(SYS-MTX) in 120 pediatric cancer survivors. A comprehensive neuropsychological 
battery was administered to all subjects. Results revealed the detrimental effects of CRT 
on posterior, nondominant hemispheric abilities. Specifically, CRT in combination with 
IT-MTX had devastating effects on cognitive abilities, even when controlling for CNS 
cancer. Also, children treated with IT-MTX and CNS radiation therapy (CRT) have been 
documented to be at risk for experiencing more educational and employment barriers 
(Rouke & Kazak, 2005). 
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Bone Marrow Transplant (BMT) 
Changes in neuropsychological capacity over time have been noted in children 
with ALL who were treated with a BMT, particularly in cognitive and motor skills (Parth, 
Dunlap, Kennedy, Ordy, & Lane, 1989). Achievement abilities, memory, and fine motor 
skills have also been found to be at risk for decline in BMT survivors (Cool, 1996). 
Children younger than the age of three and treated with total body irradiation 
demonstrate more cognitive deficits (Phipps, 2005). Kramer, Crittenden, DeSantes, & 
Cowan (1997) found a significant cognitive decline in survivors of BMTs one year post 
treatment, which remained stable up to three years post treatment. Authors concluded 
that these children are at risk for academic problems.  
Age at Diagnosis 
The age of diagnosis is an important contributor to both neurocognitive and 
psychosocial functioning. Vainionpaa (1993) suggested that younger, less developed 
bodies are more susceptible to cytotoxic therapy, causing greater mobility struggles 
than experienced by older children being treated for cancer. Children with 
medulloblastomas treated before the age eight demonstrated greater declines in their 
intellectual abilities, specifically nonverbal abstract reasoning, general fund of 
information, and overall intellectual ability than those treated over age eight (Palmer, 
Goloubeva, Reddick, Glass, Gajjar, Kun, et al., 2001). Children diagnosed with cancer 
before the age of five show more cognitive decline, memory deficits, and motor 
problems than children diagnosed after the age of five or six (Winqvist et al., 2001; 
Armstrong et al., 1999).  
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Children treated for a brain tumor before the age of six are at a greater risk for 
difficulties in educational and employment areas. Barrera, Wayland, Agnostino, Gibson, 
Weksberg, and Malkin (2003) reported that younger children demonstrated more 
externalizing behavior problems, hypothesizing that older children have more difficulties 
repressing their anger. In contrast, Koocher and OMalley (1981) reported that 
psychosocial maladjustment was associated with older age of diagnosis. Overall, it 
appears younger age of diagnosis negatively influence neurocognitive functioning, while 
diagnosis in adolescence negatively influences psychosocial functioning in survivors. 
Sex 
Sex has also been documented as influencing psychosocial adjustment. For 
example, Langeveld et al. (2004) reported that female survivors of childhood cancer 
between the ages of 16 and 49 at least five years off-treatment endorsed more 
pathology overall than males, namely in the areas of physical functioning, overall health 
perception and pain, and mental health.  
On the other hand, male survivors have been found to be more depressed and 
anxious, as well as less active, than female survivors (Chang, Nesbit, Youngren, & 
Robison, 1987). The direction and magnitude of the effects of sex on cancer treatment 
appears to be dependent on age, in addition to the type of injury and its location 
(Kadan-Lottick & Neglia, 2005). 
Factors Associated with Better Psychosocial Functioning 
Better psychosocial functioning has been associated with shorter treatment 
duration (Koocher & OMalley, 1981), longer time since diagnosis (Cella & Tross, 1986), 
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and less functional impairment (Elkin et al., 1997). Concerning personal factors, better 
psychosocial functioning has been associated with better level of functioning before 
diagnosis (Kupst, Natta, Richardson, Schulman, Lavigne, & Das, 1995), lower level of 
personal distress (Last & Grootenhuis, 1998), and better cognitive functioning (Boman 
& Bodegard, 2000).  
Previous Research in the Connection between Neurocognitive and Psychosocial 
Functioning 
Eiser (2004) described the range of stressors dealt to children with cancer to 
include understanding their condition (diagnosis, treatment, and prognosis), adapting to 
treatment and its side-effects, relating to medical staff, identifying with family and 
peers, dealing with their medical and home world, and their feelings of being different. 
Eiser et al. (2000) described three areas in which psychosocial functioning has been 
measured in the field; namely, general mental health, lifestyles and health behaviors, 
and academic and cognitive functioning. That is, each of these three factors is 
important aspect to the quality of life of children surviving cancer.  
Regardless of type of treatment, pediatric cancer survivors are at risk for 
academic decline, particularly in arithmetic abilities (Copeland, Moore, Francis, Jaffe, & 
Culbert, 1996). Butler and Copeland (2002) made the assertion that more 
neuropsychological deficits compromise academic success and, ultimately, the survivors 
quality of life. Furthermore, academic functioning has been reported to be a 
contributing factor to the social functioning in survivors. To explain, Newby et al. (2000) 
demonstrated that academic functioning best predicted social skills in these children, 
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accounting for 20% of the variance in the childs social skills. Namely, more academic 
difficulties were associated with more psychological functioning difficulties as rated by 
both parents and teachers. Also, Boman and Bodegard (2000) found that better 
psychological functioning is related to less cognitive difficulties. 
Purpose of Current Study 
With the increase in survival rates, concerns have been raised of psychosocial 
quality of life in childhood cancer survivors. Research has gravitated toward studying 
these children as these children leave the hospital and return to their previous life. 
Past literature has reported inconsistent findings concerning psychosocial 
functioning in childhood survivors. While several authors have hypothesized reasons this 
discrepancy occurs, there is still much to answer. Varni et al. (1998) suggest these 
discrepancies result from the heterogeneity of research participants and from 
characteristics such as age at diagnosis, intensity of treatment, and time since diagnosis. 
Furthermore, there is limited research in this area. Brandlyn et al. (1995) reported that 
only 3% of published clinical trials in pediatric oncology were found to include data 
related to issues of quality of life. 
In addition, there are several facets encompassing quality of life, including 
general mental health, lifestyles and health behaviors, and academic and cognitive 
functioning (Eiser et al., 2000). One of these domains of quality of life that has been 
consistently documented as a significant risk for decline in childhood cancer survivors is 
cognitive functioning (Conglio & Blackman, 1995; Winqvist et al., 2001). Furthermore, 
survivors with more cognitive deficits have been found to have more adjustment 
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difficulties (Boman & Bodegard, 2000). Also, treatment variables, such as diagnosis and 
type of treatment, have been reported to influence both cognitive and psychosocial 
functioning in survivors (Armstrong et al., 1996; Lottick & Neglia, 2005, Reimers et al., 
2003). Therefore, a connection has been established between psychosocial functioning, 
cognitive functioning, and effects of treatment variables.  
However, more specific domains of cognitive functioning, such as neurocognitive 
abilities, have not been studied with regards to their effect on psychosocial functioning 
in pediatric cancer survivors. To this date, most studies researching these two factors 
have used broad measures of cognitive functions, such as the FSIQ from the Wechsler 
scales. Furthermore, treatment variables have not been explored in terms of how and 
to what extent they affect psychosocial functioning. Since survivors have been 
documented to have greater cognitive deficits and children with greater cognitive 
difficulties tend to have greater adjustment difficulties, this project evaluated the role 
that treatment and neurocognitive variables play in psychosocial functioning of pediatric 
cancer survivors. Exploring the relationship between specific treatment factors, 
neurocognitive abilities (opposed to broad cognitive ability) and psychosocial 
adjustment can illuminate specific areas in which intervention is most warranted.  
Research Hypotheses 
First, it is hypothesized that children treated with combination therapy will be at 
risk for more behavior problems compared to children treated with surgery or 
chemotherapy only. This anticipated outcome is consistent with previous findings by 
Reimers et al. (2003). Authors found radiation therapy to be the most important 
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predictor for cognitive deficits. Langeveld et al. (2002) discovered that children treated 
with IT-MTX and CRT are at risk for experiencing more educational and employment 
barriers. Hill, Kornblith, Jones, Freeman, Holland, and Glicksman (1998) found survivors 
of ALL treated with chemotherapy and methotrexate are at risk for psychological 
problems. Survivors treated with surgery and chemotherapy alone exhibit more positive 
neurocognitive outcomes (Copeland, deMoor, Moore, & Ater, 1999).  
Second, it is hypothesized that children treated with a BMT will be at risk for 
more behavior problems compared to children treated with surgery or chemotherapy 
only. According to Vannatta (1998), peers have rated BMT survivors to have fewer 
friends, to be more socially isolated, and to be less physically attractive. Also, BMT 
survivors demonstrate declines in social competence, self-esteem, and emotional well- 
being (Phipps, 2005). 
Third, it is predicted that survivors of brain tumors will demonstrate more 
behavior problems than survivors of ALL. This hypothesis is consistent with previous 
findings of Fuemmeler et al. (2002) and Mulhern et al. (1993) who reported that 
children diagnosed with brain tumors have more social competency deficits. Also, Rutter 
et al. (1970) found children with brain-damage are at three times more risk for 
psychological maladjustment compared to children with chronic illness with no CNS 
involvement. Furthermore, Eiser et al. (2004) reported that children with CNS tumors 




Fourth, it is hypothesized that children diagnosed with cancer in middle 
childhood (ages six to twelve) will demonstrate more behavior problems than children 
diagnosed before the age of six. This may be accounted for by the obstacles created by 
the cancer experience toward achieving a sense of identity and intimacy. Koocher and 
OMalley (1981) reported older age at diagnosis to be associated with psychosocial 
maladjustment. Eiser (2004) reported that the cancer experience in adolescents creates 
obstacles to their achieving a sense of identity and intimacy.  
Fifth, it is hypothesized that survivors with more neuropsychological deficits will 
be rated as having more behavior problems. Although Boman and Bodegard (2000) 
reported that less cognitive deficits are related to better psychosocial functioning. No 
previous research is available in this population regarding the relationship between 
neuropsychological variables and psychological functioning. Therefore, an exploratory 






Participant demographic information and test data were obtained from an 
existing archival database comprised of patients of the Hematology/Oncology Center at 
Cook Childrens Medical Center in Fort Worth, TX. Data was collected as part of a 
standard neuropsychological battery given to patients referred to the Center over the 
past five years who are on-treatment or off-treatment for cancer. The data from these 
files were archived in the Department of Psychology/ Neuropsychology at Cook 
Childrens Medical Center. Survivors between the ages of three and twelve were 
selected who meet the following criteria: have finished treatment, have been 
administered all the selected measures, and meet the time since diagnosis criteria.  
Participant characteristics are presented in Table 3. The total sample of 177 
participants consisted of 107 males (61%) and 70 females (39%). Of the entire sample, 
69 (39%) were diagnosed with acute lymphoblastic leukemia (ALL) and 108 (61%) 
were diagnosed with a brain tumor. The average time since diagnosis was 3.58 years, 
ranging from 2 to 13 years. The average time off treatment was 2.56 years, ranging 
between 1 and 13 years. The average age at diagnosis was 4.36 years, ranging from 0 
to 12 years. Among the treatment modalities, 34 (19%) were treated via surgery only, 
53 (30%) were treated via chemotherapy only, 23 (13%) were treated via bone 
marrow transplant (BMT), 67 (38%) were treated with a combination of treatments 




Behavioral Assessment System for Children 
The Behavior Assessment System for Children System (BASC, AGS Publishing, 
www.agsnet.com) uses an approach to evaluating behaviors and self-perceptions of 
children ages 2.5 to 18 that is multimodal and multidimensional (Reynolds & Kamphaus, 
1998). The BASC approach includes a comprehensive set of rating scales that are quick 
and easy to score, aiming to quantify the behaviors and emotions of children and 
adolescents.  
This instrument includes symptoms from the Diagnostic and Statistical Manual of 
Mental Disorders: Third edition-Revised (DSM-III-R, American Psychiatric Association, 
1997), helping with the diagnostic differentiation process in children and adolescents. 
Problem behaviors identified by the BASC are designed to be the focus of intervention. 
Adaptive skills are also identified, which can be integrated into interventions to improve 
the childs behavior. The BASC instrument is highly applicable in the pediatric population 
due to the connection between academic difficulties and adjustment problems, such as 
low self-concept or anxiety. Furthermore, the BASC identifies emotional disturbance.  
Development 
Originally, the authors wrote definitions of behaviors to be reviewed by 
psychologists and doctoral students. After definitions were established, professionals 
with experience in several different areas wrote items, including psychology, psychiatry, 
and teaching. This instrument went through two different tryouts before the final item 
selection for teachers, parents, and students to complete was finished. The final 
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standardization sample was collected from 116 testing sites across the United States, 
including schools, preschools, and daycare centers. For example, in the sample for the 
parent rating scale (PRS) for ages 6-11 years, the sample included 1,027 females and 
1,057 males. The race/ethnicity breakdown included 139 African American, 96 Hispanic, 
1,815 White, and 34 Other. 
Normative Sample 
Clinicians were given the choice of normative samples: general, female, male, or 
clinical. The general sample was representative of a large national-based sample 
regardless of sex, race, special education classification, or parent education levels. The 
Female and Male normative samples were derived from the general sample. This 
sample allowed the clinician to separate out behaviors that are unusual for a childs age 
and sex. Finally, the clinical Norms, available for ages four and older, compared the 
individuals responses to a population of children and adolescents with psychopathology. 
When a childs responses are extremely elevated compared to the general sample, 
using the clinical norms are indicated (Reynolds & Kamphaus, 1998). 
Validity Scales 
Validity scales were provided to detect threats to validity, including carelessness, 
failure to attend to item content, portrayal of the child in overly positive or negative 
light, lack of motivation, or poor comprehension. Also, emotional disturbances or limited 
knowledge of the child being evaluated can limit validity of the informants responses. 
For the parent rating scale (PRS), the f-scale (fake bad) identified response sets that 
are excessively negative, based on items that were infrequently endorsed in the 
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standardization sample. If the f-scale is high, the respondent is attempting to make the 
child look bad, or the child actually does have a large number of serious behavioral or 
emotional problems. The scales have high internal consistency and test-retest reliability. 
Forms 
There are three different forms: the parent rating scale (PRS), the teacher rating 
scale (TRS), and the self-report rating scale (SRS). For the purposes of this project, 
only the PRS was used. The PRS is a useful instrument in measuring both adaptive and 
problem areas in the home setting. It has three different forms for different age groups, 
including pre-school, child, and adolescent. The PRS is appropriate for ages two to 18 
years. It takes approximately 10-20 minutes to complete and has a four choice 
response format.   
Composite Scales 
The PRS scales can be divided into either clinical or adaptive scales. Within the 
clinical scales, maladaptive behaviors are assessed. Clinical scales include aggression, 
anxiety, attention problems, atypicality, conduct problems, depression, hyperactivity, 
somatization, and withdrawal scales. Clinical scales are not provided for ages 2 to 3.11. 
Composite scores are also derived to summarize the childs performance, including the 
childs adaptive and maladaptive behaviors. Adaptive scales include adaptability, social 
skills, leadership, activities of daily living, and functional communication. 
The externalizing problems composite score is a composite of the hyperactivity, 
aggression, and conduct problems scales. This composite measures disruptive behavior 
problems, as well as uncontrolled behaviors. Adults readily see these behaviors because 
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the child may be more unresponsive to adult direction and disruptive (Reynolds & 
Kamphaus, 1998).  
The internalizing problems composite consists of the anxiety, depression, and 
somatization subscales. This composite score measures anxiety, depression, and similar 
areas of concern that are not marked by acting out behaviors. These types of behaviors 
may not be as noticeable as externalizing behaviors since the child may not be 
disruptive (Reynolds & Kamphaus, 1998).  
The behavior symptoms index (BSI) is a composite score that provides an 
overview of problematic behaviors since it is derived from a combination of central 
scales. Contributing scales include aggression, hyperactivity, anxiety, depression, 
attention problems, and atypicality. The BSI provides valuable information and can aid 
in determination of the global assessment of functioning (GAF) from the DSM manuals 
(Reynolds & Kamphaus, 1998).  
The adaptive skills composite for the PRS includes adaptability (ages 2.5 to 11 
only), leadership (ages 6 to 18 only), and social skills (all ages) scales. This composite 
score indicates how well the child adapts to changes in their environment, their ability 
to interact with peers and adults in a variety of settings, and how their skills associate 
with working with others (Reynolds & Kamphaus, 1998).  
Interpretation of Composite Scores 
BASC composite scores are represented as T-scores (M = 50, SD = 10). Clinical 
maladjustment is indicated at T-scores above 70 for clinical scales and T-scores below 
30 for adaptive scales. For clinical scales, at-risk ranges consist of T-scores between 60 
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and 69. For adaptive scales, at-risk T-scores range from 31-40. Average scores range 
from 59 or lower and 41 of higher for adaptive scales. In the event a child has 
significant problems, their scores may ceiling when compared to general norms 
(Reynolds & Kamphaus, 1998).  
Validity of the BASC 
Factor and structural equation analyses for the externalizing and internalizing 
composite scales have supported construct validity. The BASC correlates highly with the 
Child Behavior Checklist (CBCL; Achenbach System of Empirically Based Assessment. 
http://www.aseba.org, Achenbach, 1991), and moderately with the Personality 
Inventory for Children  Revised (PIC-R; Western Psychological Services, 
http://www.wpspublish.com, Lachar, 1990). The BASC system may actually be superior 
to the CBCL and has generally good reviews (Adams & Drabman, 1994; Gladman & 
Lancaster, 2003). Furthermore, construct validity was documented in the following 
clinical groups: conduct disorder, depression, Attention Deficit Hyperactivity Disorder, 
mild mental retardation, and autism (Reynolds & Kamphaus, 1998). 
Reliability of the PRS 
The internal-consistency for the PRS composite scores range from the 
middle .80s to low .90s at each of the three different levels, with reliabilities for the BSI 
ranging from .88 to .94. Overall, these composite scores are highly reliable, suggesting 
they are measuring the same domain of behavior (Reynolds & Kamphaus, 1998). The 
median test-retest reliability values are .85, .88, and .70 for each of the three different 
age ranges. Attention Problems, social skills, hyperactivity, and depression scales are 
 
 53
the most reliable subscales, with atypicality and conduct problems composite scales 
have relatively low reliability. The inter-parent reliability for the PRS composite scores 
are moderate, varying between .46, .57, and .67 for each of the three different age 
ranges (Reynolds & Kamphaus, 1998).  
NEPSY: A Developmental Neuropsychological Assessment 
The NEPSY (Harcourt Assessment, www.harcourtassessment.com), originally 
the NEPS, was developed in 1980 in Finland as a brief assessment for children ages 5.0 
to 6.11 years (Korkman, 1980). Further test development resulted in the addition of 
new subtests (Benton, Sivan, Hamsher, Varney, & Spreen, 1983). Subtests with poor 
reliability were eliminated and new items were added to adapt the instrument to a 
wider age range. The standardization sample consisted of 1,000 children between the 
ages of 3.0 and 12.11 years, which were then stratified for race and ethnicity, gender, 
parent education, and geographical region (Kemp, Kirk, & Korkman, 2001). Validation 
studies were conducted on clinical samples. Korkman, Kirk, and Kemp then published 
the NEPSY in 1998 as a developmental neuropsychological assessment. All the subtests 
of the NEPSY were standardized on the same, fully represented standardization sample 
(Kemp et al., 2001). 
Alexander Lurias Theory 
This instrument was founded in the theory of A.R. Luria (Luria, 1963). Luria 
conceptualized four interconnected levels of neurocognitive disorders and 
brain/behavior relationships: the structure of the brain, the functional organization of 
the brain based on structure, syndromes and impairments arising from brain disorders, 
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and clinical methods of assessment (Kemp et al., 2001). Luria divided the brain into 
three blocks: block I includes structures such as the diencephalon, brainstem, and 
medial regions of each hemisphere, responsible for life-sustaining activities, such as 
respiration and heartbeat, as well as attention necessary for cognitive functioning. Block 
II includes the posterior cortex, involved in information encoding and processing, as 
well as associating incoming information with past experience. Block III includes the 
frontal lobes, which regulate executive functioning, including behavior regulation, 
problem solving, and sequencing. Block III is affected both by the attentional processes 
of Block I and the information processing functions of block II (Kemp et al., 2001).  
Blocks I, II, and III all play an integrative role in facilitating neurocognition. 
Impairment in one subcomponent of a certain function will not only influence other 
components contributing to more complex functions, but may also negatively affect the 
development of successive subcomponents of that function. Therefore, the NEPSY 
instrument measures these basic and complex subcomponents that comprise more 
complex capacities within different functional domains (language, memory, etc.; Kemp 
et al., 2001). 
Purpose of the NEPSY 
The NEPSY was developed as a well validated and reliable instrument designed 
to identify subtle impairments in different domains that can highlight areas that can 
impede learning. Other purposes of the NEPSY are to assess the influence of congenital 
or acquired brain damage and their affect on development and to aid in determining 
normal and atypical brain development in children. The NEPSY was also developed for 
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long-term follow-up monitoring in children with congenital and acquired brain damage 
(Korkman et al., 1998).  
Core Domains and Subtests 
This instrument assesses five different areas of functioning: attention/executive 
functioning, language, sensorimotor, visuospatial, and memory and learning. For 
purposes of this study, only the core subtests will be assessed. Different core subtests 
are administered based on the age of the child (see Table 1 for subtests). The NEPSY 
takes about two hours to administer to school-aged children (Ahmad and Warriner, 
2001). Domains scores are calculated as standard scores (M = 100, SD = 15). 
The attention/executive functioning core domain measures several facets, 
including executive functions (Tower, ages 5 to 12), simple, selective, and auditory 
attention (Auditory Attention, ages 5 to 12), response set shifting (Response Set, ages 
5 to 12), visual attention (Visual attention, all ages), and basic motor persistence 
(Statue, ages 3 to 4; Korkman et al., 1998). A word of caution: Ahmad and Warriner 
(2001) warn that the domain of attention/executive Functioning should be examined 
carefully, as some reviews warn that it may not be possible to measure executive 
functioning in young children.  
The language core domain measures different areas of language, including 
naming abilities (Body Part Naming, ages 3 to 4); auditory discrimination and 
phonological awareness (Phonological Processing, all ages), rapid access to alternating 
language labels (Speeded Naming, ages 5 to 12), and receptive language 
(Comprehension of Instructions, ages 5 to 12; Ahmad and Warriner, 2001).  
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The sensorimotor core domain aims to measure dexterous finger movements 
(Finger Tapping, ages 5 to 12), kinesthetic praxis and tactile processing (Imitating Hand 
Positions, all ages), and graphomotor speed and accuracy (Visuomotor Precision, all 
ages; Ahmad and Warriner, 2001). The visuospatial Processing Core domain assesses 
abilities to integrate visuospatial input and motor output (Design Copying, all ages), to 
judge line orientation (Arrows, ages 5 to 12), and to reproduce three dimensional block 
constructions from models (Block Construction, Core ages 3 to 4, Expanded ages 5 to 
12; Ahmad and Warriner, 2001).  
The memory and learning core domain assesses immediate and delayed memory 
for faces (Memory for Faces, all ages), immediate and delayed memory for names 
(Memory for Names, all ages), verbal memory (Narrative Memory, all ages) and 
auditory short term memory (Sentence Repetition, Core ages 3 to 4; Expanded ages 5 
to 12; Ahmad and Warriner, 2001). 
Reliability and Validity  
The average reliabilities for the 5 to 12 age group range from 0.79 to 0.87 for all 
five functional domains (Anastasi & Urbina, 1997). Korkman et al. (1998) administered 
the NEPSY to 168 children on two separate occasions, concluding that the stability 
coefficients range from 0.68 (attention/executive Function) to 0.90 (Memory and 
Learning). Correlation between the NEPSY and academic grades was low (Korkman et 
al., 1998). Moderate correlations have been documented with other neuropsychological 
measures (Korkman et al, 1998).  
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Ahmad and Warriner (2001) warned that validity estimates of the NEPSY may be 
premature and much more research needs to be generated in this area. Kemp et al. 
(2001) cited a few limitations of this instrument, including that the subtests are not 
highly correlated with the general domain scales, partly because the instrument was 
developed based on theory and not factor analysis. Authors also stated that it is 
cumbersome to score (Kemp et al., 2001). 
Procedure 
 Data from an anonymous archival data set including the BASC and NEPSY 
instruments for children diagnosed with ALL or brain tumors were assessed. Type of 
diagnoses, age at treatment, and type of treatment were also collected from the 
database. Criterion for inclusion also required the children to be off-treatment and the 
evaluation to have been conducted at least two years post-diagnosis. For patients that 
had received multiple evaluations, their first evaluation, assuming it was at least two 
years post-diagnosis, was selected.  
 The type of treatment the child received was categorized into one of four 
groups: neurosurgery only, chemotherapy only, combination of treatments, or bone 
marrow transplant (BMT). The combination of treatments category included a mixture 
of any combination of the following: neurosurgery, chemotherapy, and radiation 
therapy. Diagnoses were classified as either brain tumor or ALL. Children with other 
diagnoses, including Wilms tumor, acute myelogenous leukemia (AML), 
hemophagocytic lymphohistiocytosis, static encephalopathy, Hurler's Syndrome, 
Hodgkin's lymphoma, traumatic brain injury, aplastic anemia, and sickle cell anemia 
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were excluded from this study. Cases in which the childs diagnosis or type of treatment 
was unavailable were also excluded. Age at diagnosis was classified into one of four 
groups: less than one year, one year to three years, three years to six years, and six 
years to twelve years. 
The neurocognitive factors consisted of the five NEPSY composite factors from 
the NEPSY, including attention/executive functioning, language, sensorimotor, 
visuospatial, and memory/learning. The NEPSY factors were categorized into one of 
four groups based on the clinical classifications denoted by Kemp et al. (2001, see 
Table 1 and 2 for NEPSY core subtests for different ages). Standard scores above 91 
represented the non-impaired, at expected level group, characterizing percentile ranks 
greater than the 26th percentile in the normative sample. The second category 
represented standard scores in the slightly below expected level range, accounting for 
percentile ranks between the 11th and 25th percentile. Standard scores within this range 
include 82 to 90.  
The third category represented scores in the mild to moderately impaired level, 
referred to as below expected level by Kemp et al. (2001). Standard scores falling 
within this impairment group range between 70 and 81, accounting for percentile ranks 
between the 3rd and 10th percentile. The fourth category represented the severely 
impaired group, also referred to as well below expected level by Kemp et al. (2001). 
Inclusive standard scores range from 69 and lower, representing the 2nd percentile 
ranks and lower. The dependent variable, the BSI composite score from the BASC, 
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remained continuous. This scale, discussed as an overview of problematic behaviors, is 
a combination of clinical scales from the BASC. 
Data Analysis 
Standard procedures for assuring normality, linearity, multicollinearity, 
homogeneity of variances, and describing the population were performed. A 
conservative approach was used in data analysis such that only participants who 
completed all of instruments were included in the analysis.  
Univariate descriptive analyses were performed on demographic and treatment 
variables. A one-way analysis of variance (ANOVA) with Tukeys honestly significant 
difference (HSD) test was conducted to determine the mean difference between type of 
treatment and behavior problems and the effect of age at diagnosis on behavior 
problems. An independent sample t-test was conducted to determine the relationship 
between diagnosis and behavior problems. A univariate ANOVA was performed, 
entering the coded NEPSY variables as factors and the BSI as the dependent variable. 
Welchs statistic was used to test the homogeneity of variance assumption because it is 
more sensitive to unequal group sizes than Levenes statistic (Garson, n.d.).  
An analysis of covariance (ANCOVA) could not be performed for this analysis for 
several reasons. First, covariates in an ANCOVA model should be continuous (Garson, 
n.d.). Since type or treatment and diagnosis are categorical, these variables were not 
appropriate covariates for an ANCOVA model. Furthermore, age at diagnosis was not 




Therefore, a post hoc hierarchical multiple regression was conducted to 
determine to what degree treatment variables (type of treatment, diagnosis, and age at 
diagnosis) and neuropsychological variables (attention/executive functioning, language, 
sensorimotor, visuospatial, and memory and learning) accounted for variance in overall 
behavior problems. Treatment variables were entered simultaneously in the first block. 
Then, the treatment variables were entered into the second block as covariates, 
followed by the five neuropsychological variables. The dependent variable was the 
overall composite for problematic behaviors, as measured by the BSI.  
Finally, odds ratio analyses were performed on the treatment and 
neuropsychological variables in order to observe the likelihood of survivors to 
demonstrate more behavior problems than not. The median of the BASC BSI standard 
scores were calculated to use as the reference point to examine which survivors 
demonstrate more problematic behaviors than the others. The median was also used as 





For all demographic and treatment categorical variables, counts and percentages 
are provided in Table 3. Means and standard deviations for the behavior symptom index 
(BSI) from the Behavior Assessment System for Children (BASC) are also presented in 
Table 3. For each of the five neurocognitive domains, counts and percentages are 
presented in Table 4. The correlation matrix for all variables is presented in Table 5. An 
alpha level of .05 was used for all statistical tests. 
An independent samples t-test was conducted to determine the relationship 
between type of diagnosis and problematic behaviors. The homogeneity of variance 
assumption was met, Levenes statistic, F = 1.46, p = .23. Results indicated that 
children diagnosed with acute lymphoblastic leukemia (ALL, n = 69, M = 48.71) 
demonstrate more behavior problems than children diagnosed with brain tumors (n = 
108, M = 46.03), t (175) = 2.24, p = .03. The mean difference between the ALL and 
brain tumor sample was 2.68 points. The odds ratio analysis for ALL compared to brain 
tumor survivors was statistically significant, odds ratio = 1.88, CI = 1.02 to 3.49,         
p = .04. 
A one-way analysis of variance (ANOVA) was performed to test differences 
between type of treatment and behavior problems. The homogeneity of variances 
assumption was met, Levenes statistic, F = 1.63, p = .18. The omnibus test of the 
main effect of type of treatment was statistically significant, F (3, 173) = 4.88, MS = 
283.25, p < .01. Tukeys honestly significant difference (HSD) test revealed survivors 
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treated with chemotherapy (n = 53) showed more behavior problems than those 
treated with neurosurgery only (n = 34), SE = 1.67, p = .01, CI = 0.94 to 9.63. 
Children treated with a combination of treatments (n = 67) demonstrated more 
behavior problems than children treated with neurosurgery alone (n = 34), SE = 1.60, 
p < .01, CI = 1.01 to 9.33. Survivors of BMT (n = 23) exhibited more behavior 
problems than survivors of neurosurgery only (n = 34), SE = 2.06, p < .01, CI = 1.25 
to 11.92. No other significant differences were found between treatment groups and 
behavior problems. The odds ratio analysis for surgery compared to other treatments 
was statistically significant, odds ratio = .25, CI = .11 to .59, p < .01. None of the odds 
ratio analyses for the other treatment variables were statistically significant. 
A one-way ANOVA was conducted to determine the relationship between age at 
diagnosis and behavior problems. The homogeneity of variances assumption was met, 
Levenes statistic, F = .90, p = .45. The omnibus test of the main effect of age at 
diagnosis was not statistically significant, F (3, 173) = .75, MS = 46.52, p = .52. 
 A univariate ANOVA was conducted to uncover the main effects and interaction 
effects between neurocognitive variables and overall behavior functioning (see Table 6). 
The homogeneity of variances assumption was met for attention, Welchs statistic, F = 
1.58, p = .20, language, Welchs statistic, F = 1.17, p = .33, sensorimotor, Welchs 
statistic, F  = .10, p = .96, visuospatial, Welchs statistic, F = .30, p = .83, and memory 
and learning, Welchs statistic, F = .12, p = .95. A significant omnibus test of the main 
effect was found for attention and behavior problems, F (3, 105) = 6.62, MS = 288.48, 
p < .001. Tukeys HSD test revealed that survivors with severe (way below expected 
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level) attention deficits (n = 29) demonstrate more behavior problems than those with 
average (at expected level) attention skills (n = 86), SE = 1.42, p = .04, CI = .18 to 
7.58 and low average (slightly below expected level) attention abilities (n = 39), SE = 
1.62, p = .04, CI = .18 to 8.63. The main effect of language and behavior was 
significant, F (3, 105) = 2.93, MS = 127.92, p = .04. However, none of the simple main 
effects were statistically significant. The effect of sensorimotor abilities was not 
statistically significant, F (3, 105) = .99, MS = 42.95, p = .40. The effect of visuospatial 
abilities was not statistically significant, F (3, 105) = 1.61, MS = 70.36, p = .19. The 
effect of memory was not statistically significant, F (3, 105) = .64, MS = 27.97, p = .59. 
None of the odds ratio analyses for the neuropsychological variables were statistically 
significant. 
 A post hoc hierarchical multiple regression was conducted to predict behavior 
problems from treatment variables and neuropsychological variables. The model 
included all neuropsychological variables and treatment variables, identifying the 
treatment variables as covariates to control for their effects on the relationship between 
neuropsychological factors and problematic behavior. Results for the model were 
significant, F (8, 168) = 2.90, p < .01. The model accounted for 12% of the variance in 
behavior problems (R Square = .12). After controlling for the effects of the treatment 
variables, visuospatial functioning also emerged as a significant neuropsycological 
predictor of behavior problems, ß = -.22, t = -2.35, p = .02. Type of treatment was 
also a significant predictor, ß = .20, t = 2.59, p = .01. Diagnosis was a significant 
predictor, ß = -.17, t = 2.03, p = .04. The attention factor was close to significance, ß 
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= .17, t = 1.90, p = .06. There were no other variables in the model that were 





Results support the hypotheses that survivors treated with combination of 
chemotherapy, radiation therapy, or neurosurgery and bone marrow transplant (BMT) 
demonstrated more behavior problems than children treated with neurosurgery alone. 
This finding is also consistent with studies conducted by Eiser et al. (2004), Reimers et 
al. (2003), Moleski (2000), Armstrong et al. (1999), and Kramer et al. (1997) which 
examined the effect of treatment variables on psychosocial functioning.  
Possible explanations for differences in the effects of type of treatment may be 
due to the neurotoxic effects of chemotherapy and radiation therapy. Both 
chemotherapy and radiation therapy have both been found to cause brain calcifications 
and impede white matter development in survivors (Moore, 2005). White matter loss 
has been associated with cognitive deficits (Wolf, Ecke, Bettin, Dietrich, & Gertz, 2000), 
as well as problems in speed of processing, memory, and executive functioning 
(Gunning-Dixon & Raz, 2000). Children with cognitive difficulties, such as with 
processing information and memory, may have more difficulty with emotional responses 
which could likely be affecting how they process and respond negative emotions 
behaviorally (Boman & Bodegard, 2000). 
Mulhern, Merchant, Gajjar, Reddick, and Kun (2004) reported that children 
treated by neurosurgery alone demonstrate less severe declines in their intellectual 
abilities than other treatment modalities. Consequently, this implies that survivors 
treated with chemotherapy and/or radiation therapy are experiencing more cognitive 
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deficits, as found in this study, and thus are at an increased risk for psychological 
difficulties (Boman & Bodegard, 2000).  
 In fact, the effect of type of treatment is quite influential throughout this study. 
To explain, this study finds child survivors of ALL are 1.88 times more likely to 
demonstrate behavioral problems than survivors of brain tumors. Researchers 
hypothesize treatment type is largely responsible for behavioral differences observed 
between these two groups. That is, neurosurgery is often the primary treatment for 
survivors of brain tumors (Tomita, 2000). If additional therapies are required, their 
efficacy is enhanced with more complete the resection (Ater et al., 2005). On the other 
hand, the length of treatment and aggressiveness of therapy doses differ in the ALL 
population. That is, the typical treatment duration for children with ALL is typically 
longer, ranging between two and a half to three years (Margolin et al., 2001). Children 
treated via BMTs, typically ALL survivors in this study, are treated with high doses of 
chemotherapy and radiation therapy (Kurtzberg & Clements, 2006). Thus, children 
treated with neurosurgery only (i.e. brain tumor survivors) demonstrate 25% less 
behavioral problems.  
Contrary to prediction in this study, older age at diagnosis is not significantly 
related to behavior problems. However, since the neuropsychological instrument chosen 
for this evaluation is designed for children between the ages of three and twelve, 
children outside this age range were not included in this study. Age exclusion may have 
potentially confounded the relationship between age at diagnosis and behavior 
problems. Research has documented that adolescents are more at risk for behavior 
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problems. Shelby, Nagle, Barnett-Queen, Quattlebaum, and Wuori (1998) found that 
adolescent survivors of ALL exhibited more deficits in their adaptive behaviors and more 
internalizing behavior problems than elementary-age survivors. Furthermore, 
researchers found adolescents to have a higher risk for social maladjustment in 
comparison to other ages (Poggi et al., 2005). Also, Poggi et al. (2005) found that 
longer time since diagnosis was related to more cognitive and psychological impairment. 
Therefore, it is possible that this sample of survivors may exhibit more impairment in 
time. Overall, this adolescent population is certainly of interest and will benefit from 
further study.  
Concerning neuropsychological factors, survivors in this study exhibit more 
neuropsychological deficits compared to the NEPSY normative sample. Visuospatial 
functioning is predictive to behavioral difficulties in survivors. This finding is consistent 
with that of Copeland (1992), which found ALL survivors treated with cranial radiation 
therapy (CRT) experience significant difficulties with visuospatial organization compared 
to the control group. Second, attention abilities influence behavior problems in this 
study and significant deficits in attention may predispose children to more problems in 
their behavior. Finally, survivors language abilities affect their psychosocial functioning.  
It is important to note that attention and language factors are highly correlated, 
a finding consistent with Tirosh and Cohens (1998) conclusions. Tirosh and Cohen 
(1998) discovered significant incidence of language deficits in a sample of children with 
attention difficulties. Therefore, it seems the survivors psychological functioning is 
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susceptible to a mutually shared characteristic in the language and attention factor 
scores, such as listening skills that could affect both language and attention abilities. 
Based on these results, the effects of type of treatment and neuropsychological 
variables on psychosocial health lie on a continuum. Children treated with neurosurgery 
only are at one end of this continuum, exhibiting minimal visuospatial, attention, and 
language deficits and thus fewer behavior difficulties. As children receive therapies in 
addition to neurosurgery, such as neurosurgery with chemotherapy and/or radiation 
therapy, chemotherapy only, or BMTs, they are more likely to demonstrate more 
attention, visuospatial, and language deficits and subsequent behavior problems. 
Overall, it is concluded that there are additional factors affecting behavior in this 
population that were not accounted for in this study, in addition to type of treatment 
and neuropsychological functioning, such as child, family, and environment factors, as 
also proposed by Last and Grootenhuis (1998) and Hill et al. (2003). Davies (2004) 
listed several factors related to resiliency in children and are listed as follows: easy 
temperament, internal locus of control, positive self-esteem, and active coping style. 
The childs temperament, referred to as biologically based personality traits that affect 
the childs orientation to the world (Davies, 2004, pp. 70) may certainly be a mediating 
factor in the relationship between neuropsychological, treatment, and psychosocial 
functioning. The childs temperament and the psychological adjustment in mothers of 
children with cancer are two crucial predictors of the psychological health in the 
survivors (Barrera et al., 2003).  
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The literature shows a link between parental health and psychological functining 
in survivors, as proposed by Kazak et al. (1997), who found family variables may 
influence psychological adjustment. Kazak and colleagues examined 130 mothers of 
childhood leukemia survivors, reporting a prevalence of severe Posttraumatic Stress 
Disorder (PTSD) in 10.2% of mothers, as compared to 2.8% in the comparison group of 
148 mothers of healthy children. Researchers found that posttraumatic symptoms in 
parents of childhood cancer survivors are related to more communication problems and 
reports of less satisfaction in the family. Drotar (1997) indicated psychological 
adjustment in mothers of cancer survivors directly influences the childs psychological 
functioning. Furthermore, children of parents with mental illness may display difficulties 
with emotional regulation, poorer self-concepts, or insecure attachments with their 
parents (Davies, 2004). Researchers found higher family adaptability and cohesiveness 
(Newby et al., 2000) and open communication in the family (Kupst & Schulman, 1988) 
to account for less of behavior problems in child cancer survivors.  
The literature also supports environmental variables that may also be influencing 
the relationship between type of treatment, neuropsychological functioning, and 
psychosocial functioning in this study. In children who sustained severe traumatic brain 
injuries, six-month and one-year follow-up evaluations found socioeconomic status 
(SES) to be a mediating factor in posttraumatic stress symptoms in survivors (Levi, 
Drotar, Yeates, & Taylor, 1999). Children living in poverty are more likely to score lower 
on cognitive and academic tests, exhibit externalizing behaviors, be exposed to 
environmental toxins and violence in the community, and have difficulty accessing 
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proper health care services (Davies, 2004). On the contrary, Butler et al. (1999) 
discovered contrary findings that SES is not a consistent predictor of psychological 
functioning in childhood cancer patients and survivors.  
Limitations of the Study 
Numerous limitations are noted in this study. First, no comparison group was 
included. Winqvist et al. (2001) stated that a comparison group is essential in pediatric 
oncology research. Zebrack and Chesler (2002) cautiously interpreted their findings due 
to the lack of comparison group in their study. Shelby et al. (1998) recommended the 
use of demographically matched comparison groups of healthy children and other 
chronically ill children. 
Secondly, concerning treatment variables, the types of chemotherapeutic and 
radiation drugs used to treat the participants were unavailable, as well as their doses. 
Furthermore, the method of administration of the treatments was unknown. Adjustment 
difficulties have been linked to more intensive chemotherapy treatment (Zebrack & 
Zeltzer, 2002 review). Higher doses of radiation therapy may also place the child at 
more risk for intellectual deficits (Mulhern & Palmer, 2001). Therefore, it is 
recommended for future studies to account for this information when researching these 
variables to determine their potential contribution of the relationship.  
Third, any medication the child may have been taking was unavailable. 
Medications the child was taking, such as psychostimulants or corticosteroids may have 
influenced the expression of both neurocognitive and psychosocial functioning. The 
presence of psychostimulants could potentially increase performance on the cognitive 
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scales (Brown & Sawyer, 1998). Mulhern et al., (2004) reported methylphenidate, a 
common psychostimulant, has positive effects on sustained attention and vigilance, and 
perhaps on social relationships. Psychiatric side-effects of corticosteroids may include 
hypomania, mood swings, sleep difficulties, anxiety, and personality changes (Brown, 
1998). Dexamethasone therapy, a corticosteroid, may increase the risk for 
neurocognitive late effects in children treated for ALL (Brown, 1998).  
Recommendations for Future Research 
Based on the results from the current study, it would be beneficial to study the 
individual clinical scales of the Behavior Assessment System for Children (BASC) to 
determine the exact effects of type of treatment, diagnosis, and neuropsychological 
functioning on internalizing and externalizing behaviors. The dependent variable, the 
behavior symptom index (BSI) represented an overall composite of the clinical scales on 
the BASC. However, the BSI only answers whether the childs behavior is worse than 
their peers behavior. While the clinical scales were beyond the scope of this study, 
Reynolds and Kamphaus (2002) discuss that the use of composite scores is limited and 
do not provide as good of benefits as the individual scales.  
Furthermore, this study illustrates that the attention, visuospatial, and language 
factors from the NEPSY influence psychosocial functioning in survivors. However, the 
individual scales that comprise these factor scores were not available for analysis. 
Researching these individual subtests is imperative to understanding their effect on 
psychosocial health. To explain, the attention factor also incorporates measurements of 
executive functioning which makes it difficult to disentangle which contributes more to 
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that factor. Additionally, the language factor measures both expressive and receptive 
language skills. Based on the composite factor scores, it is difficult to determine which 
of these areas is most affecting psychological health in survivors. 
 Several studies have emphasized the importance of obtaining information from 
multiple informants. Bradlyn, Ritchey, Harris, Moore, OBrien, Parsons, et al. (1996) 
proposed a multifaceted definition of quality of life for children (QOL) with cancer;  
QOL in pediatric oncology is multidimensional. It includes, but is not limited to, 
the social, physical, and emotional functioning of the child or adolescent, and 
when indicated, his/her family. Measurement of QOL must be from the 
perspective of the child, adolescent, and family, and it must be sensitive to the 
changes that occur throughout development. (p.1333-4) 
Therefore, it is recommended for additional studies to include measures from parents, 
teachers and the child themselves. 
Likewise, longitudinal studies would illuminate the long-term effects of these 
relationships. While this study included participants at least two years post diagnosis, 
the years since the child was diagnosed ranged from two to thirteen years. While 40% 
of the evaluations occurred two years post diagnosis, the range in years since diagnosis 
may be a confound variable in this study. That is, numerous studies have documented a 
decline in intelligence over several years (Mulhern et al., 2004). In survivors of posterior 
fossa brain tumors, researchers found a gradual decline in intellectual abilities over a 
four year time period, averaging two points during the early phase of treatment 
(Spiegler, Bouffet, Greenberg, Rukta, & Mabbott, 2004). Palmer, Gajjar, Reddick, Glass, 
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Kun, Wu, et al. (2003) found survivors of medulloblastomas treated with radiation 
therapy lost 2.2 intelligence points per year over a seven-year study period.  
Finally, the results from this study suggest that there are variables not accounted 
for in this study that are affecting psychosocial functioning in survivors. The factors 
discussed in the previous section, including child, family, and community variables, 
include essential factors that may be influencing the effects of the cancer experience on 
the child. Future studies need to explore variables to determine their effect on both 
neurocognitive and psychosocial functioning.  
Implications for Practice 
There are numerous implications of this study. This study explains some of the 
discrepancy in findings in the psychosocial literature. Results of this study suggest that, 
to some extent, type of treatment and diagnosis, as well as attention, visuospatial, and 
perhaps language deficits influence later development of behavior problems. While 
children have been repeatedly found to demonstrate substantial neuropsychological 
deficits, it appears there are other factors in addition to neuropsychological functioning 
that are affecting their quality of life. This study provides evidence to the importance of 
looking at other factors that may place survivors at risk for developing psychosocial 
difficulties. Though several studies have found that these survivors are functioning well 
psychologically (Zebrack & Chesler, 2002; Eiser et al., 2000; Mulhern et al., 1993; Elkin 
et al., 1997), others have reported later problems with intimacy, being teased, finding 
employment, etc. (Kazak et al., 1997; Rouke & Kazak, 2005; Boman & Bodegard, 1995).  
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Also, attention, language, and visuospatial abilities are predictive variable of 
behavior problems in this study, regardless of treatment variables. Returning to school 
for survivors is already stressful due to the change in their physical appearance (Spirito 
et al., 1991) and difficulties in social relationships may compound this stress (Butler et 
al., 2001). Thus, survivors may be struggling with difficulties in their educational, social, 
and psychological worlds.  
In all, it is imperative to help the child easily transition into his everyday life 
while observing for latent aftereffects. This research provides justification for screening 
survivors for neuropsychological and psychosocial difficulties as they are returning to 
school. This study highlights several areas to be cognizant of when working with 
survivors. Perhaps cognitive rehabilitation programs can incorporate a psycho-
educational component in order to target potential survivors who are experiencing both 
neurocognitive and psychosocial difficulties.  
There has been an effort in the pediatric oncology field toward positive 
psychology. Phipps (2005) suggests the field of psycho-oncology focus on factors that 
contribute to the healthy functioning of survivors rather than spending research efforts 
to discover the difficulties they are having. Past research has tended to focus on the 
assessment of maladjustment, rather than coping, adaptation, and resilience (Chang, 
1991; Eiser & Havermans, 1994). Therefore, this study implies that children treated 
with surgery only and those who demonstrate average to above average attention and 
language abilities are less at risk for developing psychological difficulties. Further, this 
study insinuates that perhaps neurocognitive deficits alone do not significantly affect 
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how these children are functioning when they leave the hospital and return home and 
to school.  
Perhaps the factors discussed by Hill et al. (2003), such as encouragement from 
the parents and teacher involvement, are in fact compensating for actual deficits in 
some of these children. In addition to the need for more research in this area as 
discussed above, improving the relationship between parents and teachers and working 
on the parent-child relationship could be very useful tools to include in rehabilitation 
programs. 
Mulhern and Palmer (2001) suggest that psychologists follow an explicit plan to 
formally assess cancer survivors at set times to survey for known neurocognitive deficits 
or problems they may be at risk of developing. The present study indicates several 
factors that may place survivors at risk for developing psychosocial difficulties, namely 
type of treatment, as well as attention, visuospatial, and language deficits. As 
suggested by the present study, established psychosocial problems or risk factors for 
developing psychosocial difficulties should also be included in this prospective plan of 
assessment. Therefore, by more specifically addressing the comprehensive needs of this 









NEPSY Core Subtests for Ages 3 to 4 
Domain Subtests 
Attention/executive functioning Visual attention 
Statue 
Language  Body part naming 
Phonological processing 
Sensorimotor  Imitating Hand Positions 
Visuomotor Precision 
Visuospatial  Design copying 
Block construction 
Memory and learning Memory for faces 








NEPSY Core Subtests for Ages 5 to 12 
Domain Subtests 
Attention/executive functioning Tower 
Auditory attention and response set 
Visual attention 
Language  Phonological processing 
Speeded naming 
Comprehension of instructions 
Sensorimotor  Imitating Hand Positions 
Visuomotor Precision 
Fingertip tapping 
Visuospatial  Design copying 
Arrows  
Memory and learning Memory for faces 






Demographic and Dependent Variable Summary (N = 177) 
 
     Standard  
Variables  Mean  deviation  Range 
 
Age at dx   4.36      2.95    0 - 12 
Years since dx  3.58      1.89    2 - 13 
Years off tx   2.56      1.96    1 - 13 
BASC BSI          47.07      7.87           29 - 67 
 
Variables    N  Percentage   
 
Sex      
 Male    107  61% 
 Female   70  39% 
Diagnosis 
 Brain tumor    108  61% 
 ALL      69  39%  
Type of treatment 
 Surgery only   34  19% 
 Chemotherapy only  53  30% 
 Combination   67  38% 




Demographic and Dependent Variable Summary (N = 177) 
Variables    N  Percentage  
 
Age at diagnosis 
 > 1 year   8  5% 
 1 - 3    51  29% 
 3 - 6    65  37% 


























Language 81 (46%) 20 (11%) 44 (25%) 32 (18%) 
Sensorimotor 34 (19%) 51 (29%) 58 (33%) 34 (19%) 
Visuospatial 101 (57%) 21 (12%) 32 (18%) 23 (13%) 




Intercorrelations Among Variables 
           
Scale 1 2 3 4 5 6 7 8 9 
1. Age Diagnosis -         
2. Diagnosis .35** -        
3. Treatment .03 -.13 -       
4. Attention .15* .06 .18** -      
5. Language .17* .03 .25** .57** -     
6. Sensorimotor -.20* .13 .05 .26** .37** -    
7. Visuospatial -.21** -.13* .15* .28** .44** .45** -   
8. Memory .02 .14* .10 .34** .43** .27** .40** -  
9. BSI -.03 -.17* .23** .16* .10 -.03 -.07 .02 - 




Univariate Analysis of Variance for Neuropsychology Factors 
Source Df SS MS F P 
Attention 3 865.45 288.48 6.62    .00** 
Language 3 383.77 127.92 2.93  .04 
Sensorimotor 3 128.85 42.95 .99 .40 
Visuospatial 3 383.77 70.36 1.61 .19 
Memory 3 211.07 27.97 .64 .59 
Error 105 4680.95 41.79   
Total 177 403102.00    




Summary of Hierarchical Regression Analysis for Variables Predicting Overall Behavior 
Problems (N = 188)  
   
Variable β t p 
Step 1    
  Age at Diagnosis .01 .13 .89 
  Diagnosis -.14 -1.83 .07 
  Treatment .21 2.87   .00* 
Step 2    
  Age at Diagnosis -.06 -.72  .47 
  Diagnosis -.17 -2.03   .04* 
  Treatment .20 2.59     .01** 
  Attention .17 1.89  .06 
  Language .05 .51 .61 
  Sensorimotor -.01 -.07 .95 
  Visuospatial -.22 -2.35   .02* 
  Memory .04 .43 .67 
Note. R² = .07 or Step 1;  R² = .12 for Step 2 (p < .01) 
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